https://www.inhsu.org/resource/treatment-of-the-hepatitis-c-in-prison-in-france-in-2011-2012-more-patients-treated-in-fewer-medical-jailhouse-units-results-of-national-practice-survey/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/evaluation-of-two-community-controlled-peer-support-services-for-assessment-and-treatment-of-hepatitis-c-virus-infection-in-opioid-substitution-treatment-clinics-the-ethos-study-australia/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/the-effect-of-social-functioning-and-living-arrangement-on-treatment-intent-specialist-assessment-and-treatment-uptake-for-hepatitis-c-virus-infection-among-people-with-a-history-of-injecting-drug-us/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/care-provided-for-hepatitis-c-congruence-between-patient-self-identity-and-stereotypes-applied-by-general-practitioners/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-access-via-a-community-drug-treatment-service/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/preferences-for-hepatitis-c-testing-application-of-a-discrete-choice-experiment-with-methadone-users-in-tayside-scotland/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/can-dried-blood-spot-testing-for-hepatitis-c-in-community-pharmacy-increase-uptake-interim-reporting-of-a-quasi-experimental-study/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/how-do-methadone-users-experience-community-pharmacy-a-qualitative-study-to-explore-the-important-attributes-when-designing-a-hepatitis-c-virus-testing-and-treatment-pathway/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/hepatitis-c-and-associated-injecting-risk-behaviours-in-people-who-inject-drugs/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/response-to-daa-based-hepatitis-c-treatment-on-pwud-in-substitution-therapy-first-real-life-data-from-southern-switzerland/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/the-hepatitis-c-epidemiology-public-health-researchdemic-amongst-men-who-have-sex-with-men-modelling-the-role-of-behavioural-risk-heterogeneity-and-hiv-dependent-mixing-patterns/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/a-national-multidisciplinary-healthcare-network-for-treatment-of-hepatitis-c-in-people-who-inject-drugs-in-slovenia/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/blood-borne-hepatitis-in-opiate-users-in-iran-a-poor-outlook-and-urgent-need-to-change-nationwide-screening-policy/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/the-potential-impact-of-a-hepatitis-c-vaccine-for-people-who-inject-drugs-is-a-vaccine-needed-in-the-age-of-direct-acting-antivirals/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/hepatitis-c-is-there-hope/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/strategies-to-manage-the-hcv-disease-burden-in-slovenia/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-prevalence-among-people-who-inject-drugs-in-switzerland/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/identifying-the-social-capital-of-men-in-prison-screening-positive-for-hcv/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/tools-of-screening-viral-hepatitis-b-or-c-in-real-life-new-french-model-of-care/ 2021-01-20T02:54:55+00:00 https://www.inhsu.org/resource/the-potential-prevention-impact-of-scaling-up-hepatitis-c-virus-treatment-for-people-who-inject-drugs-in-prison-a-modeling-analysis-for-scotland/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/the-community-pop-up-clinic-as-a-tool-of-engagement-for-vulnerable-populations-with-hcv-and-hiv-infection/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/swiss-data-on-hepatitis-c-treatment-in-people-who-use-drugs-the-sammsu-cohort/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/c-edge-co-star-adherence-and-drug-use-in-hcv-infected-persons-who-inject-drugs-pwid-on-opioid-agonist-therapy-oat-receiving-grazoprevir-elbasvir-gzr-ebr-fixed-dose-combination-fdc-for-12-we/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/female-to-male-ratio-of-hepatitis-c-virus-incidence-a-systematic-review-and-meta-analysis/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/liver-disease-knowledge-and-acceptability-of-non-invasive-liver-fibrosis-assessment-among-people-who-inject-drugs-in-the-drug-and-alcohol-setting-the-liverlife-study/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/dry-blood-spot-dbs-testing-in-injecting-drug-users/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/uptake-for-hcv-screening-and-treatment-in-persons-in-opiate-substitution-therapy-post-in-belgium/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/pilot-study-combining-formal-and-peer-education-with-fibroscan-to-increase-hcv-screening-and-treatment-in-persons-who-inject-drugs/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/telaprevir-in-combination-with-peginterferon-and-ribavirin-in-former-injection-drug-users-with-chronic-hepatitis-c-findings-of-the-observational-integrate-study/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/historical-and-geographical-trends-in-incidence-of-hepatitis-c-virus-hcv-infection-among-people-who-inject-drugs-the-inc3-study/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/evaluation-of-treatment-of-hcv-infection-in-active-injection-drug-users/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/will-the-moment-of-hepatitis-c-diagnosis-undermine-the-promise-of-new-treatments-an-analysis-of-canadian-womens-experiences/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/characterising-hepatitis-c-virus-transmission-dynamics-in-a-high-risk-incarcerated-population/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/willingness-to-be-treated-for-hepatitis-c-among-prisoners-results-from-the-national-prison-entrants-bloodborne-virus-and-risk-behaviour-survey-npbbvs/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-for-people-who-inject-drugs-are-direct-acting-antivirals-cost-effective/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/engaging-and-curing-active-drug-users-of-hepatitis-c/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/factors-associated-with-undiagnosed-hepatitis-c-infection-among-people-who-inject-drugs-missed-opportunities-for-diagnostic-testing-in-the-united-kingdom-uk/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/managed-care-networks-increase-hcv-testing-and-referral-within-community-drug-services/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/hcv-hiv-co-infected-pwid-treated-for-hcv-at-inner-city-clinic/ 2021-01-20T02:55:04+00:00 https://www.inhsu.org/resource/changeing-the-pharmacotherapy-experience-for-people-who-use-illicit-drugs/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/the-next-step-in-collaborative-hcv-care-pwid-partnerships-and-potential-to-treat/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/hcv-testing-and-linkage-for-people-who-inject-drugs/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/hepatitis-see-low-literacy-hepatitis-c-guide-for-people-who-inject-drugs/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/empowering-conscious-health-consumers-in-an-changing-treatment-landscape/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/impact-of-opiate-substitution-therapy-and-needle-syringe-programmes-on-incidence-of-hcv-a-systematic-review-and-meta-analysis/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/estimating-the-burden-of-hepatitis-c-virus-infection-in-iran-how-the-enhanced-antiviral-treatments-can-prevent-the-rising-burden/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/experiences-of-pwid-community-network-in-linking-hcv-testing-and-care-to-treatment-using-direct-acting-antivirals/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/hepatitis-c-reinfection-following-sustained-virological-response-a-seven-year-follow-up-of-norwegian-patients-infected-through-injecting-drug-use/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/a-single-tablet-regimen-of-ledipasvir-sofosbuvir-is-efficacious-and-well-tolerated-among-people-receiving-opiate-substitution-therapy/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/engaging-substance-users-in-advocacy-campaigning/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/pregnancy-and-contraceptive-use-among-young-women-who-inject-drugs-in-a-hepatitis-c-virus-vaccine-preparedness-study/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-uptake-among-patients-receiving-opioid-substitution-treatment-a-population-based-study/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/hiv-and-hepatitis-c-treatment-uptake-among-people-who-use-drugs-from-the-amsterdam-cohort-studies-1985-2013/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/positive-impact-of-a-community-based-educational-intervention-on-access-to-hcv-testing-in-difficult-to-reach-people-who-inject-drugs-results-from-the-anrs-aerli-study/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/improving-quality-and-scaling-up-access-to-hcv-treatment-for-the-most-at-risk-populations-within-resource-limited-settings-of-ukraine/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/opportunistic-versus-standard-hepatitis-b-vaccination-for-people-who-inject-drugs-pwid-in-the-supermix-cohort/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/onward-transmission-of-hepatitis-c-virus-infection-among-younger-and-older-people-who-inject-drugs-in-vancouver-canada/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/drawing-them-in-stories-from-people-who-know/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/cost-effectiveness-of-treating-chronic-hepatitis-c-virus-with-direct-acting-antivirals-in-people-who-inject-drugs-in-australia/ 2021-01-20T02:55:11+00:00 https://www.inhsu.org/resource/hepatitis-b-and-c-care-in-the-opiate-substitution-setting-an-integrated-nursing-model-of-care/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/access-to-blood-borne-virus-testing-and-treatment-in-a-local-high-risk-population-of-people-who-inject-drugs/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/hazardous-alcohol-use-and-concomitant-blood-borne-virus-infection-in-a-local-urban-population-of-people-who-inject-drugs-implications-for-approaches-to-harm-reduction/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/comparison-of-self-reported-blood-borne-virus-status-with-recent-serology-results-in-a-local-high-risk-population-of-people-who-inject-drugs/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/relational-and-contingent-risk-and-harm-reduction-blood-borne-virus-prevention-and-care-in-an-urban-culturally-diverse-neighbourhood/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/expanding-access-to-hepatitis-care-among-people-who-inject-drugs-pwid-one-year-of-fibroscans-at-the-kirketon-road-centre/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/high-adherence-to-short-duration-response-guided-treatment-among-people-with-recent-hcv-infection-the-atahc-ii-and-dare-c-i-studies/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/retention-in-care-and-testing-uptake-are-major-obstacles-to-daa-treatment-among-pwid-even-in-integrated-services/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/associations-between-neighbourhood-disadvantage-and-prescription-opiate-injection-in-montreal-canada/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/standard-of-care-of-hepatitis-c-in-the-addiction-medicine-clinic-centre-st-martin/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/the-modelled-impact-of-improved-hepatitis-c-virus-hcv-treatment-strategies-on-hcv-prevalence-among-people-who-inject-drugs-pwids-in-belgium/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/how-should-hcv-antiviral-treatment-be-prioritized-in-the-direct-acting-antiviral-era-an-economic-evaluation-including-individual-and-population-prevention-benefits/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/hcv-transmission-among-hiv-positive-men-who-have-sex-with-men-in-the-uk-recent-epidemiology-public-health-researchdemiology-and-modelling-the-impact-of-scaled-up-hcv-antiviral-treatment-with-new-da/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/efficacy-of-response-guided-pegylated-interferon-and-ribavirin-therapy-for-people-who-inject-drugs-with-hcv-genotype-2-3-infection-the-activate-study/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/high-connectivity-is-associated-with-hiv-co-infection-in-the-transmission-network-of-people-with-recent-hepatitis-c-virus-infection-in-australia/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/its-not-only-my-life-i-got-to-worry-about-accounts-of-needle-syringe-sharing-and-negotiated-safety-among-couples-who-inject-drugs/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/hcv-diagnostic-screening-among-people-who-inject-drugs-in-australia/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/hcv-re-infection-in-high-risk-people-who-inject-drugs/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/hcv-treatment-and-prevention-what-is-the-impact-of-current-and-scaled-up-treatment-rates-in-selected-sites-in-europe/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/modelling-the-impact-of-a-national-scale-up-of-interventions-on-hepatitis-c-virus-transmission-among-people-who-inject-drugs-in-scotland/ 2021-01-20T02:55:18+00:00 https://www.inhsu.org/resource/network-based-modeling-for-hcv-in-us-drug-injectors-treatment-as-prevention/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/high-rates-of-sustained-virological-response-in-people-who-inject-drugs-treated-with-sofosbuvir-based-regimens/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/community-derived-research-agenda-for-indigenous-peoples-with-lived-hepatitis-c-experience/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/the-challenge-to-engage-the-whole-patient-in-the-era-of-directly-acting-antiviral-daa-therapy-for-hepatitis-c-virus-hcv-infections/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/changes-in-injection-drug-use-among-recently-hepatitis-c-virus-infected-persons-who-inject-drugs-offered-treatment-in-montreal-canada/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/making-hepatitis-c-treatment-a-national-priority-in-georgia-through-drug-users-community-advocacy/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/recent-syringe-sharing-long-injecting-history-past-incarceration-and-not-living-with-the-family-are-independently-associated-with-hepatitis-c-virus-hcv-infection-among-people-who-inject-drugs-pwi/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/from-principles-to-practice-description-of-a-novel-equity-based-hcv-primary-care-treatment-model-for-pwid/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/is-increased-hcv-case-finding-combined-with-8-12-week-interferon-free-direct-acting-antiviral-treatment-cost-effective-in-uk-prisons-a-dynamic-cost-utility-analysis-including-treatment-as-prevention/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/the-mobile-hepatitis-screening-program-an-innovative-project-among-people-who-use-drugs-in-paris-region/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/from-awareness-to-treatment-a-comprehensive-hcv-model-of-care/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/integrated-hepatitis-c-services-in-drug-and-alcohol-settings-enable-engagement-and-access-to-care-a-cascade-of-care/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/treatment-of-intravenous-drug-users-idus-with-chronic-hepatitis-c-receiving-opioid-replacement-with-buprenorphine-in-central-greece-effectiveness-tolerability-and-compliance/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/incident-hepatitis-c-cases-detected-through-a-custodial-hcv-treatment-program/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/challenges-on-hcv-management-in-hcv-hiv-co-infection-patients-evidence-from-cross-sectional-study-at-nhtd-national-hospital-of-tropical-diseases-hanoi-vietnam/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/feasibility-and-efficacy-of-sofosbuvir-based-regimens-for-treatment-of-hcv-infection-in-a-low-threshold-setting/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/injecting-and-drug-use-factors-associated-with-recent-hepatitis-c-infection-new-findings-from-a-national-sample-of-people-who-injecting-drugs-in-the-united-kingdom-uk/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/indigenous-peoples-in-canada-and-hepatitis-c-stigma-deconstructed/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/hcv-treatment-as-prevention-for-pwid-is-reinfection-rate-a-useful-outcome-for-decision-makers/ 2021-01-20T02:55:25+00:00 https://www.inhsu.org/resource/fibroscan-days-as-a-tool-to-patient-engagement-in-the-cascade-of-care-for-hepatitis-c-hcv/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/trends-in-end-stage-liver-disease-among-people-receiving-opioid-substitution-therapy-with-an-hcv-notification-in-new-south-wales-australia-between-1993-and-2012/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/reduced-hcv-recurrent-viremia-in-pwid-with-treatment-induced-virologic-clearance-through-a-comprehensive-multidisciplinary-treatment-model/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/hepatitis-b-virus-hbv-serological-status-among-people-who-enter-the-opioid-substitution-programme-in-greece/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/incidence-and-predictors-of-hepatitis-c-treatment-initiation-among-people-who-inject-drugs-longitudinal-data-from-a-greek-tertiary-center-2009-2015/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/low-threshold-hepatitis-c-treatment-for-people-who-inject-drug-how-to-ensure-compliance-and-treatment-success/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/community-supported-hcv-treatment-model-in-provision-of-care-for-pwid-in-ukraine/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/global-genotype-distribution-of-hepatitis-c-viral-infection-among-people-who-inject-drugs/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/becoming-a-buddy-accordance-and-incompatibility-in-the-hepatitis-c-peer-support-role/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/modelling-hepatitis-c-virus-transmission-in-a-high-risk-incarcerated-population/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/hcv-treatment-initiation-among-hcv-infected-pwid-in-capica-a-retrospective-study-in-twelve-canadian-clinical-settings/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/effect-of-combined-harm-reduction-strategies-on-hcv-primary-and-reinfection-incidences-among-people-who-inject-drugs-in-montreal-canada/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/heroin-assisted-treatment-setting-feasibility-and-efficacy-of-hepatitis-c-daa-treatment/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/hepatitis-c-testing-in-the-general-practice-setting-for-australians-who-inject-drugs/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/the-australian-response-and-uptake-of-the-new-subsidised-hepatitis-c-direct-acting-anti-virals-among-the-community-of-people-who-inject-drugs/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/daa-2nd-generation-treatment-outcome-in-substance-users/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-rna-quantification-on-dry-capillary-blood-spot/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/fibroscan-days-as-a-tool-to-patient-engagement-in-the-cascade-of-care-for-hepatitis-c-hcv/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/trends-in-end-stage-liver-disease-among-people-receiving-opioid-substitution-therapy-with-an-hcv-notification-in-new-south-wales-australia-between-1993-and-2012/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/addressing-hiv-hcv-co-infection-among-injecting-drug-users-in-jakarta-indonesia-using-peer-driven-intervention/ 2021-01-20T02:55:33+00:00 https://www.inhsu.org/resource/efficacy-of-all-oral-hcv-therapy-in-people-who-inject-drugs/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/stable-incidence-of-hepatitis-c-virus-infection-among-people-with-a-history-of-injecting-drug-use-in-an-australian-prison-setting-the-hits-p-study/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/attitudes-towards-hepatitis-c-and-treatment-willingness-among-people-who-inject-drugs-a-follow-up-interview-study/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/c-edge-co-star-risk-of-reinfection-following-successful-therapy-with-elbasvir-ebr-and-grazoprevir-gzr-in-persons-who-inject-drugs-pwid-receiving-opioid-agonist-therapy-oat/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/stage-of-liver-disease-in-hepatitis-c-patients-at-a-low-threshold-hepatitis-c-clinic-in-oslo/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/high-hepatitis-c-virus-reinfection-rate-after-achieving-sustained-virological-response-svr-among-people-who-inject-drugs-actively-tactic-cohort/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/multi-disciplinary-managed-care-networks-lifesaving-interventions-for-hepatitis-c-patients/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/eliminating-hepatitis-c-transmission-by-enhancing-care-and-treatment-among-hiv-co-infected-individuals-the-co-ec-study/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/experiences-of-alcohol-use-and-hepatitis-c-among-people-who-inject-drugs-implications-for-treatment-services/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/hcv-capacity-building-trainings-for-harm-reduction-and-peer-workers/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/intermittent-injecting-drug-use-and-hcv-incidence-in-an-observational-cohort-study-of-people-who-inject-drugs-in-montreal-canada/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/real-world-experience-in-hcv-awareness-testing-care-and-knowledge-transfer-in-la-ronge-saskatchewan/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/past-incarceration-experience-and-the-risk-of-hepatitis-c-infection-among-people-who-inject-drugs-results-from-a-sero-behavioral-survey-among-current-injectors-in-germany/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/monitoring-hcv-among-people-who-inject-drugs-in-europe-a-set-of-indicators-to-serve-policy-and-practice/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/efficacy-of-sofosbuvir-ledipasvir-with-and-without-ribavirin-in-patients-with-chronic-hcv-genotype-1-infection-receiving-opioid-substitution-therapy-analysis-of-phase-3-ion-trials/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/efficacy-and-safety-of-sofosbuvir-velpatasvir-in-patients-with-chronic-hepatitis-c-virus-infection-receiving-opioid-substitution-therapy-analysis-of-phase-3-astral-trials/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/liver-disease-burden-and-clinical-follow-up-during-a-liver-health-promotion-intervention-integrating-non-invasive-liver-disease-screening-in-drug-and-alcohol-settings-the-liverlife-study/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-exposure-infection-and-associated-risk-behaviours-in-two-maximum-security-prisons-in-new-south-wales-australia/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/portable-pop-up-clinics-characteristics-of-engagement-in-care-an-observational-prospective-cohort-study/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/analysis-of-adherence-to-all-oral-hcv-therapy-in-a-cohort-of-people-who-inject-drugs-pwid/ 2021-01-20T02:55:40+00:00 https://www.inhsu.org/resource/exposure-to-opioid-substitution-therapy-following-hepatitis-c-notification-implications-for-provision-of-antiviral-therapies-in-drug-treatment-settings/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/modelling-the-impact-of-interventions-targeting-high-risk-populations-on-the-hcv-epidemic-in-pakistan/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/high-rates-of-sustained-virological-response-in-people-who-inject-drugs-treated-with-all-oral-direct-acting-antiviral-regimens/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/impact-of-hcv-advocacy-and-demonstration-treatment-programs-specifically-targeted-at-pwids-on-national-hepatitis-policy/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/qualitative-evaluation-of-the-decisions-and-experiences-of-people-who-inject-drugs-who-received-a-liver-disease-assessment-as-part-of-a-liver-health-promotion-campaign-the-liverlife-study/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/a-qualitative-study-of-the-perceptions-of-interferon-free-therapy-for-hepatitis-c-virus-infection-among-people-who-inject-drugs-the-liver-life-study/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/direct-observed-therapy-of-chronic-hepatitis-c-with-interferon-free-all-oral-regimens-at-a-low-threshold-drug-treatment-facility-a-new-concept-for-treatment-of-patients-with-borderline-compl/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/peer-support-for-people-living-with-hepatitis-c-in-drug-and-alcohol-settings-increases-hep-c-assessment-and-knowledge/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/ethical-research-and-engagement-with-people-who-use-drugs-frameworks-and-implementation/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/geographic-determinants-of-hepatitis-c-screening-in-a-mixed-urban-rural-epidemic/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/hepatitis-c-testing-and-undiagnosed-infections-among-people-injecting-image-and-performance-enhancing-drugs-in-england-wales-2012-15/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/factors-associated-with-entry-into-healthcare-pathways-for-hepatitis-c-among-people-who-inject-psychoactive-drugs-in-the-united-kingdom-uk/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/real-world-outcomes-of-direct-acting-antiviral-daa-therapy-for-hepatitis-c-hcv-amongst-persons-who-inject-drugs-treated-in-an-inner-city-hepatitis-c-treatment-program-vancouver-canada/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/can-health-risk-behaviours-explain-the-high-mortality-rate-for-adults-with-chronic-hepatitis-c-in-the-united-states/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/estimating-the-cascade-of-hepatitis-c-testing-care-and-treatment-among-people-who-inject-drugs-in-australia/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/infcare-needle-syringe-program-infcare-nsp-a-database-for-following-and-reducing-injection-risk-behavior-over-time-in-pwid-in-stockholm/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/pre-testing-knowledge-of-hepatitis-c-status-among-1504-consecutive-participants-at-the-stockholm-needle-exchange/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/does-chronic-hepatitis-c-cause-fatigue/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/injecting-drug-use-among-inmate-in-norwegian-prisons/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/utilising-social-capital-to-promote-hcv-treatment-in-prison/ 2021-01-20T02:55:48+00:00 https://www.inhsu.org/resource/fatigue-in-patients-with-chronic-hepatitis-c-the-fat-hep-study-a-cross-sectional-study-of-fatigue-and-its-relation-to-substance-use-and-ost/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/compass-project-inside-and-outside-link-for-prisoners-and-pwid-with-hepatitis-c-in-france/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/reinfection-of-hepatitis-c-among-people-who-inject-drugs-in-norway-opportunity-for-intervention-a-modelling-study/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/adherence-to-hepatitis-c-treatment-regimen-among-people-who-inject-drugs-in-norway-implications-for-treatment-strategies/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/aggressive-treatment-of-hepatitis-c-in-people-who-inject-drugs-in-norway-an-integral-step-to-eradicate-the-infection-in-this-population/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/comparison-of-rates-of-recurrent-hcv-viremia-in-high-risk-patients-receiving-all-oral-and-interferon-based-regimens/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/dot-c-a-pilot-trial-of-directly-observed-anti-hcv-therapy-in-a-population-receiving-opiate-substitution-therapy-ost-from-a-pharmacy-uptake-of-testing-results/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/treatment-evaluation-and-uptake-among-persons-with-chronic-hepatitis-c-on-opium-substitution-therapy-is-treatment-as-prevention-realistic/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/optimal-adherence-during-hcv-treatment-amongst-active-drug-users-at-a-community-based-program-in-toronto-canada/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/substantial-decline-of-hepatitis-c-virus-prevalence-among-pwid-in-flanders-belgium-the-result-of-a-comprehensive-approach/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/earth-study-phase-1-expanding-access-to-rapid-treatment-for-hep-c/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/changes-in-risk-behaviours-during-and-following-treatment-for-hepatitis-c-virus-infection-among-people-who-inject-drugs-the-activate-study/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/improved-access-to-hcv-treatment-for-substance-users-the-impact-of-on-site-transient-elastography-in-an-inner-city-community-health-centre/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/prospective-data-on-people-who-use-drugs-in-switzerland-the-sammsu-cohort/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/high-prevalence-of-liver-fibrosis-among-people-attending-addiction-clinics-and-rehabilitation-facilities-in-southern-switzerland-results-of-two-different-screening-programs-for-liver-disease/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/development-and-validation-of-a-novel-measurement-scale-for-interpersonal-factors-underlying-injection-drug-using-behaviors/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/relationships-and-injecting-dyads-identifying-key-interpersonal-factors-underlying-injecting-behaviors-and-hepatitis-c-virus-hcv-transmission-among-injecting-partnerships/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/dried-blood-spot-valid-screening-method-for-viral-hepatitis-and-hiv-in-real-life/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/low-levels-of-hcv-awareness-and-risk-among-groups-most-at-risk-in-vietnam/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/concordance-between-self-reported-and-measured-hiv-and-hepatitis-c-virus-infection-status-among-people-who-inject-drugs-in-germany/ 2021-01-20T02:55:56+00:00 https://www.inhsu.org/resource/qualitative-insights-into-the-lived-experience-of-interferon-free-treatments/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/trends-in-hepatocellular-carcinoma-among-people-receiving-opioid-substitution-therapy-with-an-hcv-notification-in-new-south-wales-australia-between-2000-and-2014/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/impact-of-current-and-scaled-up-levels-of-needle-and-syringe-programmes-and-opiate-substitution-therapy-in-three-uk-settings/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/baseline-characteristics-and-recruitment-in-a-randomised-trial-of-community-vs-hospital-direct-acting-antiviral-treatment-for-hepatitis-c/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/the-effects-of-alcohol-on-spontaneous-clearance-of-acute-hepatitis-c-virus-infection-in-females-versus-males-who-inject-drugs/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/hcv-infection-and-hiv-hcv-coinfection-among-new-injectors-during-an-hiv-outbreak-in-athens-greece-results-from-the-aristotle-programme/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/training-drug-users-in-overdose-reversal-with-intranasal-naloxone-a-new-approach-to-address-opioid-overdoses-and-other-general-health-problems/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/the-prison-economy-of-needles-and-syringes-what-opportunities-exist-for-hepatitis-c-risk-reduction-when-prices-are-so-high/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/the-efficacy-of-psychosocial-interventions-to-reduce-sexual-and-drug-blood-borne-virus-risk-behaviours-among-people-who-inject-drugs-a-systematic-review-and-meta-analysis/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/blood-borne-virus-risk-behaviours-among-people-who-inject-drugs-in-the-uk-a-qualitative-exploration/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/the-role-of-incarceration-in-hcv-transmission-amongst-people-who-inject-drugs-a-modelling-analysis/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/outreach-screening-and-treatment-for-hepatitis-c-in-a-drug-treatment-unit-an-exploratory-assessment-of-feasibility-and-cost-effectiveness/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/hepatitis-c-and-risk-behavior-among-persons-who-inject-drugs-in-norway/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/drug-market-variations-and-drug-use-practices-among-people-who-inject-drugs-in-the-province-of-quebec-canada/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/trends-of-hepatitis-c-virus-epidemic-in-australia-and-north-america-in-20th-century-back-projections-from-molecular-epidemiology/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/molecular-epidemiology-of-full-length-hepatitis-c-virus-genomes-among-injecting-drug-users-with-recent-infection-the-inc3-study/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-on-pwud-in-the-daas-era-high-rate-of-virological-response-in-the-real-life/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/feasibility-and-efficacy-of-sofosbuvir-based-regimens-for-treatment-of-hepatitis-c-infection-in-a-low-threshold-setting/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/prevalence-and-determinants-of-liver-disease-among-people-who-use-drugs-in-amsterdam-the-netherlands/ 2021-01-20T02:56:04+00:00 https://www.inhsu.org/resource/integrating-a-hepatitis-c-peer-support-worker-in-a-public-drug-treatment-clinic/ 2021-01-20T02:56:07+00:00 https://www.inhsu.org/resource/scaling-up-hcv-treatment-syringe-services-and-medicated-assisted-treatment-for-achieving-rapid-hcv-elimination-in-rural-america-model-projections-for-indiana/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/c-buddies-missing-piece-of-the-puzzle-in-a-comprehensive-not-under-one-roof-approach-for-hepatitis-c-management-among-people-who-use-drugs/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/hiv-hcv-hbv-screening-and-fibroscan-sessions-in-paris-dcr/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/real-word-effectiveness-of-interferon-free-sofosbuvir-based-regimens-in-patients-with-opioid-substitution-therapy-german-hepatitis-c-registry-data/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/realworld-evidence-for-improvement-of-clinical-symptoms-and-wellbeing-of-ost-patients-after-ifn-free-sofosbuvir-based-regimen-therapy-dhc-r-data/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-in-people-who-inject-drugs-pwids-the-end-of-venous-blood-monitoring/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-by-primary-care-teams-in-inner-city-community-health-clinics-a-prospective-cohort-study/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/eradicate-c-study-treating-chaotic-drug-users-to-eliminate-hepatitis-c-the-final-report/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/hcv-treatment-for-people-who-inject-drugs-co-located-within-a-needle-syringe-program/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/efficacy-and-safety-of-sofosbuvir-based-direct-acting-antiviral-daa-therapies-for-hcv-infection-in-patients-receiving-opioid-substitution-therapy-ost/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/implementation-of-a-nurse-led-model-of-care-to-treat-people-who-inject-drugs-pwid-for-hcv-in-the-community/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/daas-show-very-high-efficacy-in-idus-with-chronic-hepatitis-creceiving-opioid-replacement-with-buprenorphine-in-central-greece/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/hcv-reinfection-and-injection-risk-behavior-following-elbasvir-grazoprevir-treatment-in-participants-on-opioid-agonist-therapy-co-star-three-year-follow-up-study/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/motivation-information-and-substance-use-are-barriers-to-hcv-treatment-initiation-in-hiv-hcv-co-infected-patients/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/assessment-of-hepatitis-c-at-the-malmo-needle-exchange-program-sweden/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/efficacy-and-safety-of-sofosbuvir-velpatasvir-in-people-with-chronic-hcv-infection-and-recent-injecting-drug-use-the-simplify-study/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/c-buddies-missing-piece-of-the-puzzle-in-a-comprehensive-not-under-one-roof-approach-for-hepatitis-c-management-among-people-who-use-drugs/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/scaling-up-hcv-treatment-syringe-services-and-medicated-assisted-treatment-for-achieving-rapid-hcv-elimination-in-rural-america-model-projections-for-indiana/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/high-rates-of-sustained-virological-response-in-people-who-inject-drugs-treated-with-sofosbuvir-based-regimens-in-ukraine/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/combining-the-expansion-of-medicated-assisted-therapies-and-hcv-treatment-among-pwid-in-ukraine-insights-from-network-modeling/ 2021-01-20T02:56:13+00:00 https://www.inhsu.org/resource/reversal-of-fibrosis-following-successful-hcv-therapy-among-hiv-hcv-co-infected-people-who-use-drugs-pwid/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/near-patient-serial-transient-elastography-ste-improves-hepatitis-c-treatment-uptake-among-patients-on-opioid-substitution-treatment-ost/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/dot-of-sofosbuvir-ribavirin-peginterferon-with-minimal-monitoring-for-the-treatment-of-hepatitis-c-in-people-who-use-drugs-in-chennai-india-c-dot/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-in-community-pharmacies-an-effective-way-of-ensuring-excellent-svr-rates-in-people-on-opiate-substitution-therapy/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/community-prescribing-of-hepatitis-c-treatment-a-nurse-led-model-to-increase-treatment-uptake-by-people-who-inject-drugs/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/randomized-controlled-trial-of-cash-incentives-or-peer-mentors-to-improve-hcv-linkage-and-treatment-among-hiv-hcv-coinfected-persons-who-inject-drugs-the-champs-study/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/hepatitis-c-resistance-associated-substitutions-among-people-who-inject-drugs-treated-with-direct-acting-antiviral-containing-regimens-in-the-prevail-study/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/feasibility-and-efficacy-of-direct-acting-antiviral-therapy-for-treatment-of-hepatitis-c-infection-in-a-low-threshold-setting/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/re-engagement-of-clients-with-hepatitis-c-attending-a-substance-misuse-service-following-an-education-day-to-community-psychiatric-nurses-cpns/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/real-life-hcv-treatment-data-from-an-inner-city-dublin-hospital-clinic/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/treatment-adherence-among-people-who-inject-drugs-taking-directly-observed-direct-acting-antiviral-therapy-at-kirketon-road-centre/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/delivering-direct-acting-antiviral-therapy-to-highly-marginalised-populations-in-an-integrated-primary-health-care-setting/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/the-impact-of-alcohol-dependence-on-hcv-treatment-initiation-in-hiv-hcv-coinfected-patients-within-a-randomized-controlled-trial-investigating-a-psychosocial-behavioral-intervention/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/barriers-to-widespread-hepatitis-c-treatment-among-people-who-inject-drugs-data-from-the-sammsu-cohort/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/models-of-care-for-the-management-of-hepatitis-c-among-people-who-inject-drugs-in-southern-switzerland-role-of-nurses/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/hcv-reinfection-following-successful-direct-acting-antiviral-treatment-among-people-who-inject-drugs-preliminary-results-from-a-low-threshold-treatment-setting/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/all-oral-anti-hcv-therapy-in-injecting-drug-users-updated-real-world-data/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/hcv-infected-people-who-inject-drugs-pwid-long-term-engagement-to-prevent-recurrent-viremia-rv-in-patients-that-received-ifn-based-therapies/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/stage-of-liver-fibrosis-and-linkage-to-care-in-hcv-infected-people-who-inject-drugs-results-from-national-study-in-slovenia/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/outcomes-of-treatment-for-hepatitis-c-virus-infection-in-the-prison-setting-in-the-traphepc-treatment-as-prevention-for-hepatitis-c-program-in-iceland/ 2021-01-20T02:56:21+00:00 https://www.inhsu.org/resource/project-ittreat-integrated-community-based-test-stage-and-treat-hcv-service-for-people-who-inject-drugs-pwid/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/online-census-of-drug-consumption-rooms-dcrs-as-a-setting-to-address-hcv-current-practice-and-future-capacity/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/prevalence-of-hepatitis-c-screening-testing-and-care-experiences-among-young-adults-who-use-prescription-opioid-non-medically-in-rhode-island/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/chronic-hepatitis-c-virus-hcv-burden-in-rhode-island-modelling-treatment-scale-up-and-elimination/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/controlling-hiv-and-hcv-epidemics-among-people-who-inject-drugs-in-northwest-province-in-vietnam-based-on-evidence-from-surveys/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/how-to-set-up-a-hcv-treatment-program-within-a-busy-methadone-program-in-sydney-australia/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/highly-effective-hcv-therapy-and-low-rate-of-reinfection-in-persons-who-inject-drugs-and-receive-opioid-agonist-therapy/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/direct-acting-antiviral-daa-therapy-in-people-who-inject-drugs-pwid-with-advanced-hepatitis-c-virus-hcv-related-liver-disease/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/direct-acting-antiviral-therapy-in-patients-with-advanced-disease-comparison-of-svr-rates-between-people-who-inject-drugs-pwid-and-non-pwid/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/severity-and-correlates-of-liver-fibrosis-in-hepatitis-c-infected-people-who-inject-drugs-and-patients-infected-by-other-routes/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/the-prevail-study-intensive-models-of-hcv-care-for-people-who-inject-drugs/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/substitution-treatment-for-opioides-is-a-key-factor-for-hcv-cure-in-drug-users/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-in-people-receiving-opioid-substitution-therapy-a-difficult-population/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/paritaprevir-ritonavir-ombitasvir-dasabuvir-ribavirin-in-people-with-hcv-genotype-1-and-recent-injecting-drug-use-or-receiving-ost-d3feat-study/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/safety-and-efficacy-of-glecaprevir-pibrentasvir-in-patients-with-chronic-hepatitis-c-genotypes-1-6-receiving-opioid-substitution-therapy/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/collocation-of-hcv-treatment-buprenorphine-and-prep-to-reduce-harm-in-pwid-with-hcv-preliminary-data-from-the-anchor-study/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-with-direct-acting-antivirals-for-patients-in-opioid-substitution-treatment-and-heroin-assisted-treatment-real-life-data/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/high-treatment-uptake-despite-limited-treatment-access-at-the-basel-centre-for-addiction-medicine/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/efficacy-of-pegylated-interferon-and-ribavirin-pr-in-persons-who-inject-drugs-pwid-3-years-experience-of-one-inpatient-rehabilitation-facility/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/efficacy-and-safety-of-simeprevir-containing-hepatitis-c-therapy-in-patients-on-opiate-substitution-therapy/ 2021-01-20T02:56:29+00:00 https://www.inhsu.org/resource/c-buddies-challenges-in-the-comprehensive-approach-of-hepatitis-c-management-among-people-who-use-drugs/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/cost-effectiveness-of-ledipasvir-sofosbuvir-for-the-treatment-of-chronic-hepatitis-c-in-the-uk-a-dynamic-transmission-modelling-approach/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/combined-hepatology-addictions-advanced-fibrosis-clinic-leads-to-high-attendance-rates-amongst-cohort-with-history-of-failure-to-engage-with-service/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/meet-them-where-they-are-successful-implementation-of-hepatitis-c-screening-and-linkage-in-substance-abuse-clinics-georgia-usa/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/spreading-the-word-the-role-of-hepatitis-c-education-in-achieving-elimination/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/hcv-services-and-syringe-exchange-programs-partnering-to-improve-access-to-care-for-people-who-inject-drugs/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/utilising-a-peer-based-initiative-to-recruit-patients-for-hepatitis-c-treatment-in-a-community-needle-and-syringe-exchange-program/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/dcr-and-harm-reduction-program-hcv-capacity-building/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/hiv-serostatus-and-having-a-regular-physician-for-hepatitis-c-among-people-who-inject-drugs/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/low-hepatitis-c-seroconversion-risk-in-methadone-maintenance-treatment/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/injection-of-prescription-opioids-a-matter-of-concern-for-hepatitis-c-prevention/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/hepatitis-c-in-prisons-in-france-situational-analysis-in-2015-efficient-screening-undertreatment/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/epidemiological-and-compliance-data-for-iv-drug-users-from-a-hepatology-department-in-greece/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/potential-health-outcome-and-efficiency-gains-of-consolidating-the-hepatitis-c-screening-and-linkage-to-care-cascade-in-substance-abuse-programs/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/an-evidence-review-integrated-community-based-hcv-treatment-models-enabling-people-who-inject-drugs-to-access-hcv-treatment/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/successful-model-of-testing-and-linking-people-who-inject-drugs-pwid-to-treatment-using-direct-acting-antivirals/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/reaching-hepatitis-c-virus-elimination-targets-requires-health-system-interventions-to-enhance-the-care-cascade/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/a-cost-effectiveness-analysis-of-increasing-hcv-screening-in-pwid-in-switzerland-using-rapid-antibody-saliva-and-dried-blood-spot-testing/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/increase-in-hepatitis-c-treatment-in-a-marginalized-and-disadvantage-community-in-adelaide-south-australia/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/evaluation-of-an-intervention-designed-to-increase-diagnosis-and-treatment-of-patients-with-hepatitis-c-virus-infection-in-drug-treatment-settings/ 2021-01-20T02:56:36+00:00 https://www.inhsu.org/resource/estimating-the-cost-of-a-comprehensive-syringe-service-program-in-the-united-states/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/markov-model-to-evaluate-health-outcomes-of-sofosbuvir-velpatasvir-voxilaprevir-for-salvage-treatment-of-patients-with-chronic-hepatitis-c-in-the-us/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/health-insurance-barriers-to-direct-acting-antivirals-daas-in-a-u-s-integrated-hepatitis-c-virus-infection-hcv-methadone-maintenance-program-mmp/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/cascade-of-hepatitis-c-hcv-care-at-cups-an-inner-city-clinic-in-calgary-alberta-canada/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/liver-health-event-an-innovative-approach-to-improve-hepatitis-c-screening-and-linkage-to-care-in-indigeneous-communities/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/cost-saving-of-integrating-hcvtesting-into-hiv-testing-programs-for-pwid-using-respondent-driven-recruitment/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-outcomes-utilizing-the-echo-modeltm-in-new-mexico-prisons/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/client-acceptability-and-feasibility-of-expanded-access-to-direct-acting-antiviral-therapy-for-hepatitis-c-at-the-kirketon-road-centre/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/heplink-integrating-hepatitis-c-treatment-in-primary-care/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/linking-pwud-people-who-use-drugs-into-hepatitis-c-care/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/what-do-you-need-to-plan-and-implement-a-hepatitis-c-hcv-elimination-project-in-a-geographical-region-worked-example/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/description-of-a-hepatitis-c-treatment-program-co-located-at-a-syringe-exchange-program-in-new-york-city/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/evaluation-of-a-community-based-hepatitis-c-virus-service-project-ittreat-integrated-community-based-test-stage-treat-for-people-who-inject-drugs-pwid/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/staffs-attitudes-toward-injecting-drug-users-and-hepatitis-c/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/reducing-injecting-drug-use-risks-by-providing-foil-to-smoke-heroin-a-service-improvement-pilot-evaluation/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/clinicians-attitudes-towards-the-treatment-of-patients-with-hepatitis-c-who-are-injecting-drug-users-cathpin/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/development-of-national-strategies-plans-and-guidelines-for-hcv-treatment-in-pwid-between-2013-and-2016-in-33-european-countries/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/modeling-the-impact-of-hcv-therapy-on-people-who-inject-drugs-in-ho-chi-minh-city-vietnam/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/the-hcv-care-cascade-among-people-who-inject-drugs-in-a-norwegian-low-threshold-setting-the-major-barrier-is-fibrosis-restrictions/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/a-one-step-diagnosis-algorithm-reveals-high-burden-of-hepatitis-c-among-people-who-inject-drugs-in-spain-and-the-urgency-for-improved-linkage-to-care/ 2021-01-20T02:56:44+00:00 https://www.inhsu.org/resource/overcoming-barriers-to-chc-treatment-a-meaningful-and-effective-collaboration-of-a-public-sector-organization-with-a-patients-community-organization/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/the-community-pop-up-clinic-cpc-a-strategy-to-engage-hcv-infected-people-who-use-drugs-pwud-in-long-term-healthcare/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/resource-allocation-for-hepatitis-c-elimination-an-analytical-modeling-framework/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/hcv-prevention-and-needle-and-syringe-programs-peer-voices-enhancing-service-delivery/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/barriers-to-hepatitis-c-treatment-access-across-the-united-states-perspectives-of-public-health-officials-and-advocates/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/scaling-up-coverage-quality-of-hiv-viral-hepatitis-prevention-targeted-to-most-at-risk-population/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/accessibility-of-hcv-diagnostics-and-treatment-services-in-eastern-europe-and-central-asia-eeca/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/self-reported-competency-related-to-testing-management-and-treatment-of-hcv-infection-among-physicians-prescribing-opioid-agonist-therapy-the-c-scope-study/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/hepatitis-c-testing-care-and-treatment-at-harm-reduction-centres-in-the-european-union-a-28-country-survey-of-service-providers/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/ensuring-pragmatic-trials-work-the-precis-2-tool-to-aid-the-design-of-superdot-c-a-cluster-randomised-controlled-trial-in-pharmacy/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/the-cost-effectiveness-of-interventions-to-improve-case-finding-and-engagement-with-hcv-treatment-for-people-who-inject-drugs-in-the-uk/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/frequent-delayed-hepatitis-b-spontaneous-clearance-among-high-risk-groups/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/hepatitis-c-cascade-of-care-among-people-who-inject-drugs-in-vancouver-canada/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/measures-of-hepatitis-c-hcv-incidence-in-the-era-of-hcv-prevention/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/having-more-hiv-infected-network-members-in-care-is-associated-with-increased-hcv-treatment-uptake-among-people-who-inject-drugs/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/one-year-injecting-frequency-trajectories-as-predictors-of-hepatitis-c-acquisition-findings-from-an-observational-cohort-of-people-who-inject-drugs-in-montreal-canada/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/the-community-pop-up-clinic-cpc-a-strategy-to-engage-hcv-infected-people-who-use-drugs-pwud-in-long-term-healthcare/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/overcoming-barriers-to-chc-treatment-a-meaningful-and-effective-collaboration-of-a-public-sector-organization-with-a-patients-community-organization/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/psychiatric-and-substance-use-characteristics-are-not-barriers-for-medication-approval-and-achieving-svr-in-an-urban-hcv-population/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/successful-treatment-of-patients-on-opiate-replacement-therapy-utilising-partial-directly-observed-therapy-of-daas-in-community-pharmacies/ 2021-01-20T02:56:52+00:00 https://www.inhsu.org/resource/insufficient-hcv-testing-in-an-ost-clinic-in-stockholm-calls-for-changes-in-testing-routines/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/incidence-of-hepatitis-c-virus-infection-in-two-maximum-security-prisons-in-new-south-wales-australia-the-stop-c-study/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/needle-syringe-programmes-and-opioid-substitution-therapy-for-prevention-hcv-transmission-among-people-who-inject-drugs-cochrane-systematic-review/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/ten-fold-increase-in-hcv-treatment-uptake-among-people-who-inject-drugs-following-broad-access-to-daa-therapies-in-australia/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-hcv-mortality-attribution-by-birth-cohort-british-columbia-hepatitis-testers-cohort-bc-htc/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/recommendations-for-hepatitis-c-virus-testing-among-people-who-inject-drugs-in-australia/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/elimination-of-hepatitis-c-virus-hcv-requires-identification-of-those-infected-a-successful-identification-process-at-acute-detox-hospital/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/poor-awareness-of-hepatitis-c-virus-antiviral-effectiveness-among-people-who-actively-inject-drugs-in-the-direct-acting-antiviral-era/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/from-testing-to-viral-suppression-the-hcv-care-continuum-at-an-urban-harm-reduction-agency-and-syringe-exchange-in-philadelphia/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/a-cross-sectional-study-of-the-association-between-self-perceived-hcv-status-and-receptive-syringe-sharing-among-australians-who-regularly-inject-drugs/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/unsafe-places-syndemic-risk-factors-for-hcv-seropositivity-in-young-people-who-inject-drugs-new-york-city/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/widespread-prep-coverage-may-increase-the-prevalence-of-hepatitis-c-within-men-who-have-sex-with-men/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/injecting-risk-behaviours-among-people-who-inject-drugs-in-an-australian-prison-setting-2005-2014-the-hits-p-study/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/codisen-anrs-12334-cohort-study-on-people-who-use-injectable-drugs-in-senegal-first-results-on-hiv-and-hepatitis-prevalence/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/restrictions-for-reimbursement-of-interferon-free-direct-acting-antiviral-therapies-for-hcv-infection-in-europe/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/a-report-on-phase-one-of-the-prison-based-hepatitis-c-seek-and-treat-project-in-ireland/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/correlates-of-higher-female-to-male-hcv-infection-among-people-who-inject-drugs-results-from-the-international-multi-cohort-inc3-collaborative/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/incidence-of-hcv-among-participants-in-the-stockholm-needle-exchange-program/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/estimating-hepatitis-c-burden-in-san-francisco-quantifying-the-disproportionate-impact-on-people-who-inject-drugs/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/assessing-the-policy-response-to-hepatitis-c-in-the-nordic-countries-the-hep-nordic-study106/ 2021-01-20T02:56:59+00:00 https://www.inhsu.org/resource/cocaine-injection-patterns-over-time-among-people-who-inject-drugs-in-montreal-and-the-link-with-risk-of-hcv-infection/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/rate-of-opiate-agonist-initiation-according-to-preferred-opioid-of-abuse-among-people-who-inject-drugs-in-montreal-canada/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/characterization-of-a-population-with-hepatitis-c-infection-in-a-u-s-state-prison/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/acceptability-of-point-of-care-finger-stick-and-venepuncture-hepatitis-c-virus-testing-among-people-who-inject-drugs-and-homeless-people/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/interventions-to-enhance-testing-linkage-to-care-and-treatment-uptake-for-hepatitis-c-infection-among-people-who-inject-drugs-a-systematic-review/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-uptake-and-completion-among-young-adults-who-inject-drugs-identifying-gaps-to-inform-response/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/addressing-the-hepatitis-c-epidemic-in-criminal-justice-settings-through-academic-public-health-partnerships/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/the-changing-role-of-injecting-drug-use-in-the-hepatitis-c-virus-epidemic-in-georgia-and-paths-to-elimination/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/modelling-the-role-of-incarceration-on-hcvtransmission-amongst-people-who-inject-drugs-in-kentucky-and-impacts-of-reducing-incarceration/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/recent-incarceration-and-risk-of-hepatitis-c-and-hiv-transmission-amongst-people-who-inject-drugs-a-systematic-review-and-meta-analysis/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/prisoner-health-is-community-health-outcomes-of-a-prison-based-peer-education-project-in-new-mexico-prisons/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/modelling-hepatitis-c-virus-elimination-and-monitoring-policies-in-iceland/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/treatment-of-aboriginal-and-torres-strait-islander-clients-with-direct-acting-antivirals-at-the-kirketon-road-centre/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/incorporating-overdose-management-into-routine-care-of-people-who-inject-drugs-who-are-undergoing-hepatitis-c-treatment-with-direct-acting-antivirals/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/a-partnership-approach-to-implementing-an-elimination-program-for-hepatitis-c-a-story-from-down-under/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/low-test-uptake-of-hepatitis-c-and-hiv-among-the-young-seeking-drug-use-treatment-in-denmark-between-1996-2015/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/neighbourhood-risk-environments-and-hepatitis-c-virus-infection-among-persons-who-inject-drugs-in-montreal/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/the-road-to-hepatitis-c-elimination-in-a-tribal-health-system/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/investigating-the-impact-of-scaling-up-screening-treatment-and-prevention-interventions-targeting-priority-groups-for-hepatitis-c-virus-elimination-in-pakistan/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/per-contact-infectivity-of-hepatitis-c-virus-acquisition-in-association-with-receptive-needle-sharing-exposures-in-a-prospective-cohort-of-young-injection-drug-users/ 2021-01-20T02:57:08+00:00 https://www.inhsu.org/resource/daa-tdaa-therapy-for-hcv-infection-among-people-with-a-substance-use-history-attending-an-inner-city-community-health-centre-victoria-canada/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/phylogenetic-clustering-among-people-with-recent-hepatitis-c-virus-infection-in-australia-between-2004-2015/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-phylogenetic-clustering-and-latent-class-analysis-of-drug-use-among-people-who-use-drugs-in-vancouver-canada/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/diagnostic-burn-out-for-hepatitis-c-when-will-countries-run-out-of-diagnosed-people-to-treat-daas/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/hcv-the-silent-epidemic-an-educational-intervention/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/the-cost-effectiveness-of-needle-and-syringe-provision-in-preventing-transmission-of-hepatitis-c-virus-in-people-who-inject-drugs/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/outcomes-of-treatment-for-hepatitis-c-virus-infection-in-the-prison-setting/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/mortalty-of-hcv-infected-people-who-inject-drugs-in-limburg-a-20-year-follow-up-study/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/injection-partner-mixing-higher-risk-of-hcv-among-young-adults-who-inject-drugs-with-younger-injecting-partners/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/identifying-entering-and-characterizing-hcv-hotspot-clusters-a-mixed-methods-approach/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/implementation-of-ghost-for-detection-of-hcv-transmission-network-by-tennessee-department-of-health/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/examining-the-association-between-prescription-opioid-injection-and-hcv-transmission-during-transition-of-a-drug-epidemic-in-montreal-canada/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/incidence-of-hepatitis-c-among-hiv-infected-men-who-have-sex-with-men-msm-2000-2015/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/cost-effectiveness-of-scaling-up-hcv-prevention-testing-and-treatment-interventions-among-people-who-inject-drugs-in-the-us/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/impact-of-scaling-up-hcvprevention-and-treatment-interventions-among-people-who-inject-drugs-in-san-francisco-vs-perry-county-kentucky/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/experiences-of-uncertainty-and-stress-following-fibrosis-assesment-in-people-who-inject-drugs-living-with-hepatitis-c-melbourne-australia/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/promoting-hepatitis-c-virus-screening-and-linkage-to-care-for-opioid-users-through-a-mobile-health-system-early-experience-from-a-randomized-trial/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/comorbidities-among-hiv-hcv-coinfected-people-who-inject-drugs-pwid-a-retrospective-cohort-study/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/factors-affecting-hepatitis-c-virus-seropositivity-in-the-inner-city/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/oral-opiate-prescription-use-as-a-risk-factor-for-hepatitis-c-in-those-tested-outside-of-the-birth-cohort/ 2021-01-20T02:57:15+00:00 https://www.inhsu.org/resource/narcotics-are-cheaper-than-food-in-pakistan-our-pwids-are-dying-from-aids/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/hepfriend-a-dublin-based-peer-facilitated-model-of-engagement-in-the-hcv-care-pathway/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/hepatitis-c-homelessness-as-a-barrier-to-engagement/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/collaborative-hcv-learning-model-for-patients-and-clinicians-in-substance-use-disorder-clinics-2016-2017-findings-on-knowledge-and-perceptions/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/blocks-and-enablers-to-hepatitis-c-virus-screening-and-treatment-a-prisoners-perspective/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/harm-reduction-strategies-to-combat-hepatitis-and-the-opioid-epidemic/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/hcv-knowledge-and-risks-behaviors-among-young-suburban-people-who-inject-drugs/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/evaluating-the-impact-of-prison-based-peer-workers-on-hepatitis-c-virus-screening-in-an-irish-prison/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/naloxone-save-lives-not-when-in-pakistan/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/from-client-to-co-worker-peer-work-within-a-harm-reduction-hepatitis-c-treatment-program-in-toronto-canada/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/treatment-as-prevention-in-the-prison-setting-prisoners-perspectives/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/developing-patient-reported-outcome-measures-for-hcv-daa-treatment-among-people-who-inject-drugs-what-else-besides-cure/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/does-australias-policy-landscape-support-hcv-treatment-as-prevention-in-the-prison-setting-in-the-new-daa-era/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/health-promotion-a-continuing-role-for-peer-support-workers-in-drug-health-service-liver-clinics/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/baseline-characteristics-of-an-urban-cohort-of-patients-with-chronic-hcv-and-active-idu-challenges-and-possibilities/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/reducing-viral-hepatitis-transmission-in-persons-experiencing-incarceration-through-education-and-peer-based-interventions/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/improving-cascade-of-hepatitis-c-care-through-linkage-to-c-care-program-ltc/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/detachable-low-dead-space-syringes-for-the-prevention-of-hepatitis-c-among-people-who-inject-drugs-an-economic-evaluation/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/redefining-preparedness-for-hepatitis-c-treatment-from-the-peer-perspective/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/i-was-asked-to-leave-the-hospital-they-thought-i-was-scamming-dope-canadian-womens-experiences-of-hcv-care/ 2021-01-20T02:57:23+00:00 https://www.inhsu.org/resource/reinfection-following-successful-hcv-daa-therapy-among-people-with-recent-injecting-drug-use-the-simplify-and-d3feat-studies/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/international-ngo-collaboration-as-a-catalyst-to-effective-harm-reduction-practices-regarding-viral-hepatitis-prevention-screening-and-cure/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/hepcatt-hepatitis-c-assessment-to-treatment-trial-in-primary-care-a-cluster-rct-of-whether-a-complex-intervention-based-on-risk-prediction-algorithm-tool-and-education-can-increase-testing-and-diag/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/direct-acting-antiviral-therapy-for-hepatitis-c-virus-infection-among-people-who-inject-drugs-a-systematic-review-and-meta-analysis/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/high-proportion-of-undiagnosed-hepatitis-c-virus-hcv-infection-among-persons-who-inject-drugs-a-community-based-safety-net-hospital-experience/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/feasibility-outcome-and-uptake-of-ifn-based-and-ifn-free-daa-hcv-treatment-in-ost-patients-in-switzerland-the-sammsu-cohort/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/poor-adherence-to-hepatocellular-carcinoma-screening-in-a-cohort-of-cirrhotic-patients-after-hepatitis-c-cure/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/direct-acting-antiviral-therapy-for-hcv-infection-in-people-with-recent-injecting-drug-use-attending-an-inner-city-community-health-centre-in-victoria-canada/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/receiving-hepatitis-c-treatment-as-a-couple-romantic-partners-mutual-reduction-of-injecting-behaviour-frequency/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/telemedicine-for-the-treatment-of-hepatitis-c-a-systematic-review-and-meta-analysis/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/low-hepatitis-c-treatment-rates-among-patients-screened-as-inpatients-at-a-rural-academic-medical-center/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/recall-can-increase-treatment-uptake-an-audit-of-positive-hepatitis-c-pcr-tests-at-the-kirketon-road-centre/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/real-life-cohorts-and-the-impact-of-losses-to-follow-up-ltfu-on-hcv-sustained-virologic-response-svr-rates/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/integrated-efficacy-and-safety-of-glecaprevir-pibrentasvir-in-patients-with-psychiatric-disorders/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/elbasvir-grazoprevir-ledipasvir-sofosbuvir-and-velpatisvir-sofosbuvir-therapy-among-people-who-use-drugs-pwud-real-world-experience/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/lack-of-follow-up-after-end-of-treatment-and-recurrent-viremia-among-pwud-treated-for-hcv-infection/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/international-ngo-collaboration-as-a-catalyst-to-effective-harm-reduction-practices-regarding-viral-hepatitis-prevention-screening-and-cure/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/reinfection-following-successful-hcv-daa-therapy-among-people-with-recent-injecting-drug-use-the-simplify-and-d3feat-studies/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/reinfection-following-hcv-daa-therapy-among-people-who-inject-drugs-on-opioid-agonist-thearpy-the-prevail-study/ 2021-01-20T02:57:30+00:00 https://www.inhsu.org/resource/is-the-availability-of-direct-antiviral-agents-ddas-enough-to-treat-chronic-hepatitis-c-chc-and-achieve-hcv-elimination-among-people-who-use-drugs-pwud-what-do-the-real-world-data-suggest/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/factors-influencing-engagement-with-a-multidisciplinary-incentivised-hepatitis-c-program-for-intravenous-substance-users/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/high-cure-rates-in-a-real-world-cohort-of-hcv-infected-patients-on-opioid-substitution-therapy-ost-despite-alcohol-and-cannabis-consumption-data-from-the-german-hepatitis-c-registry-dhc-r/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/real-world-adherence-to-direct-acting-antivirals-in-a-cohort-of-people-who-use-drugs-in-rome-italy/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/preliminary-results-about-hcv-care-cascade-among-pwid-in-rome-setting-una-regione-senza-la-c-project/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/reversal-of-fibrosis-after-successful-hcv-treatment-in-people-who-inject-drugs-pwid/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/providing-access-to-hepatitis-c-treatment-improves-adherence-to-addiction-treatment-in-an-outpatient-addiction-treatment-center/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/a-phylogenetic-analysis-of-hcv-transmission-among-pwid-on-opioid-agonist-therapy-in-the-prevail-study/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/interim-results-of-an-ongoing-project-to-eradicate-hcv-in-people-who-inject-drugs-at-risk-for-non-adherence-to-direct-acting-antivirals-in-vienna/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/loss-to-follow-up-among-pwud-receiving-hcv-treatment-predictors-and-intervention-strategies/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/how-do-we-reach-the-other-75-of-people-with-untreated-chronic-hepatitis-c-in-australia/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/differences-in-sustained-virologic-response-to-direct-acting-antiviral-therapy-for-chronic-hepatitis-c-by-sex-results-from-the-canhepc-retrospective-registry/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/new-directly-acting-antiviral-therapy-of-hcv-infected-people-who-injected-drugs-real-life-experience-from-turkey/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/real-world-direct-acting-antiviral-daa-outcomes-among-people-who-inject-drugs-hepatitis-c-real-options-hero/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/direct-acting-antivirals-in-hcv-mono-infection-compared-to-hcv-hiv-co-infection-in-community-care-setting-a-real-world-experience/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/treatment-with-direct-acting-antivirals-leads-to-increased-uptake-of-injecting-equipment-provision-iep-and-low-rates-of-reinfection-results-from-a-scottish-cohort/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/enhancing-the-hepatitis-c-hcv-care-cascade-for-people-who-inject-drugs-pwid-at-the-stockholm-needle-exchange-results-from-fibroscan-examinations-and-hcv-treatment/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/hepcare-europe-hepcheck-point-of-care-hepatitis-c-testing-in-vulnerable-populations/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/can-hepatitis-c-virus-hcv-reinfection-be-predicted-and-prevented-among-people-who-currently-inject-drugs-pcid-the-potential-importance-of-understanding-and-intervening-upon-injection-networks-to/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/high-efficacy-of-direct-acting-antiviral-hcv-treatment-among-people-with-recent-injecting-drug-use-a-real-life-experience/ 2021-01-20T02:57:38+00:00 https://www.inhsu.org/resource/use-of-simplified-hcv-testing-diagnosis-and-generic-sofosbuvir-velpatasvir-treatment-leading-to-100-svr12-in-myanmar-usaid-equip-project/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/despite-high-risk-behaviors-including-chemsex-barriers-exist-for-hcv-testing-in-msm-throughout-india/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/estimating-the-number-of-people-who-inject-drugs-in-athens-greece-implications-for-the-burden-of-hepatitis-c-infection-and-the-coverage-of-harm-reduction-programs/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/sex-drugs-and-hcv-the-role-of-sex-and-sex-work-in-hepatitis-c-virus-infection-among-people-who-inject-drugs-in-montreal/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/the-cost-effectiveness-of-undertaking-hcv-treatment-in-needle-and-syringe-programmes-in-tayside-scotland/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/chronic-hepatitis-c-treatment-response-with-direct-acting-antivirals-in-patients-with-substance-abuse-a-community-hospital-based-study/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/improving-hcv-treatment-uptake-in-prison-breaking-the-60-day-barrier/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/real-world-data-on-safety-and-effectiveness-of-glecaprevir-pibrentasvir-for-the-treatment-of-patients-with-chronic-hepatitis-c-virus-infection-on-opioid-substitution-therapy-latest-results-from-the-g/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/hcv-cure-rates-among-people-who-inject-drugs-not-receiving-medication-assisted-treatment-in-an-american-indian-alaskan-native-population/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/collocation-of-buprenorphine-with-hcv-treatment-to-improve-adherence-and-reduce-harm-in-pwid-with-hcv-update-from-the-anchor-study/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/drug-use-and-reinfection-during-and-following-hepatitis-c-virus-hcv-treatment-with-elbasvir-grazoprevir-ebr-gzr-among-patients-receiving-opioid-agonist-therapy-oat-the-c-edge-co-star-study/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/low-hcv-reinfection-rate-after-treatment-in-people-who-infect-drugs-pwid-from-a-prospective-cohort-in-tbilisi-georgia/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/low-rate-of-reinfection-following-direct-acting-antiviral-hcv-treatment-among-people-with-recent-injecting-drug-use-a-real-life-experience/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-in-people-who-inject-drugs-on-medication-assisted-therapy-versus-people-attending-a-needle-exchange-program-nct03093415/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/lost-to-follow-up-patients-have-equivalent-sustained-viral-response-rates-to-patients-attending-their-scheduled-svr12-visit/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/adherence-to-sofosbuvir-and-velpatasvir-among-people-with-chronic-hcv-infection-and-recent-injection-drug-use-the-simplify-study/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/factors-associated-with-hepatitis-c-in-hiv-positive-men-who-have-sex-with-men/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/uptake-of-treatment-for-hepatitis-c-infection-in-people-who-inject-drugs-the-link-study/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/treatment-outcomes-achieved-with-all-oral-hepatitis-c-treatment-in-people-who-currently-inject-drugs-a-systematic-review-and-meta-analysis/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/combined-coverage-of-harm-reduction-interventions-and-rates-of-primary-and-recurrent-hcv-infection-in-a-community-based-cohort-of-people-who-inject-drugs/ 2021-01-20T02:57:46+00:00 https://www.inhsu.org/resource/marked-reduction-in-the-prevalence-of-hepatitis-c-viremia-in-the-prison-setting-during-2nd-year-of-traphepc-treatment-as-prevention-for-hepatitis-c-program-in-iceland/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/monitoring-hcv-elimination-as-a-public-health-threat-among-pwid-in-the-european-union/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/a-screening-program-for-hepatitis-c-among-baby-boomers-in-the-northeast-united-states-has-revealed-an-alarmingly-high-prevalence-of-hcv-infection-among-people-who-inject-drugs/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/re-setting-the-target-for-hepatitis-c-micro-elimination-in-an-isolated-uk-population/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/hcv-seroprevalence-and-risk-factors-in-a-cohort-of-people-who-use-drugs-screened-with-rapid-tests-in-rome-the-hidden-epidemic/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/the-contribution-of-injecting-drug-use-to-hepatitis-c-virus-transmission-globally-regionally-and-at-country-level-a-modelling-study/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/prevalence-and-characteristics-of-hcv-infection-in-people-who-use-drugs-managed-at-low-threshold-settings-in-slovenia-results-from-a-national-study/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/high-re-infection-rates-among-people-who-inject-drugs-successfully-treated-for-hepatitis-c-in-a-community-needle-and-syringe-programme/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/opiate-agonist-therapy-and-prevention-of-hcv-transmission-among-people-who-inject-drugs-the-importance-of-clinically-indicated-and-patient-perceived-dosage-adequacy/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/ecdc-emcdda-evidence-based-guidance-on-prevention-and-control-of-hcv-in-prison-settings/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/prevalence-of-hepatitis-c-b-and-hiv-among-people-who-use-drugs-in-three-south-african-cities/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/injection-risk-behaviors-and-hcv-infection-among-young-opioid-injectors-in-new-york-city-a-challenge-for-hcv-elimination/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/factors-associated-with-hepatitis-c-testing-uptake-among-people-who-inject-image-and-performance-enhancing-drugs/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/three-decades-of-harm-reduction-programs-in-a-country-with-liberal-drug-policies-factors-associated-with-its-uptake-among-people-who-inject-drugs-in-amsterdam/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/recruitment-methods-for-epidemiologic-research-on-hepatitis-c-among-rural-young-adults-who-inject-drugs/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/prevalence-of-viremic-hepatitis-c-virus-hepatitis-b-virus-or-hiv-infection-and-vaccination-status-among-swedish-prisoners/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/the-impact-of-high-risk-behaviors-and-hepatitis-c-on-mortality-in-drug-users-a-register-based-cohort-study-on-5350-persons-connected-to-drug-use-treatment-1996-2014/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/barriers-to-hcv-testing-in-drug-treatment-services-for-people-who-inject-drugs/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/the-hepatitis-c-pre-daa-cascade-of-care-for-persons-using-drug-services-in-england/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/origin-diversity-and-transmission-dynamics-of-hepatitis-c-virus-genotypes-in-portugal/ 2021-01-20T02:57:54+00:00 https://www.inhsu.org/resource/increased-risk-of-hepatitis-c-virus-and-skin-and-soft-tissue-infection-among-people-who-inject-novel-psychoactive-substances/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/improving-engagement-with-healthcare-in-hepatitis-c-a-randomised-controlled-trial-of-a-peer-advocacy-intervention/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/correlations-between-injecting-frequency-and-housing-stability-trajectories-evolving-concomitantly-over-one-year-results-from-a-cohort-study-of-people-who-inject-drugs-in-montreal-canada/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/housing-stability-and-hepatitis-c-infection-for-young-adults-who-inject-drugs-examining-the-effect-of-consistent-and-intermittent-housing-trajectories-on-incident-hcv-infection/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/attenuated-protective-effect-of-opioid-agonist-therapy-on-hepatitis-c-incidence-among-females/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/estimating-progression-through-the-cascade-of-care-among-patients-with-hepatitis-c-infection-in-victoria-australia-after-the-introduction-of-direct-acting-antivirals/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/inventory-and-strategies-of-development-for-preventing-screening-and-monitoring-hepatitis-c-among-drug-users/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/not-if-but-where-socio-spatial-injection-contexts-and-binge-drug-injection-in-a-prospective-cohort-of-people-who-inject-drugs-in-montreal-canada/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/epidemiology-of-injection-drug-use-and-prevention-of-hcv-infection-among-people-who-inject-drugs-in-canada-2011-2016/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/the-prevalence-of-chronic-untreated-hepatitis-c-virus-infection-and-associated-risk-factors-in-irish-prisoners-a-cross-sectional-study/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/dale-vale-tracking-the-hcv-epidemic-in-young-people-who-inject-drugs-in-new-mexico/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/injecting-risk-behaviors-and-hcv-genotypes-distribution-among-people-who-inject-drugs-attending-a-syringe-service-program-in-tunis-tunisia/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/hepatitis-c-positive-stigma-and-drug-use-challenges/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/first-line-screening-by-fibroscan-transiant-elastography-in-a-population-at-high-risk-for-hcv-infection/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/ten-year-mortality-demonstrates-that-opioid-substitute-patients-with-high-alcohol-intake-require-early-linkage-to-hepatitis-c-hcv-treatment/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/upscaling-prevention-to-control-hepatitis-c-as-a-public-health-threat-in-tanzania/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/global-multi-level-analysis-of-demographic-behavioural-and-ecological-factors-associated-with-hcv-antibody-prevalence-in-people-who-inject-drugs/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/title-is-hcv-elimination-among-hiv-infected-people-who-inject-drugs-possible-through-treating-hiv-hcv-coinfection-a-modeling-analysis-for-andalusia-spain/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/exposing-the-need-for-viral-hepatitis-c-services-for-people-who-inject-drugs-in-south-africa-findings-from-a-three-city-cross-sectional-survey/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/linking-hepatitis-c-infection-people-who-inject-drugs-to-treatment-and-care-south-africa/ 2021-01-20T02:58:02+00:00 https://www.inhsu.org/resource/cost-effectiveness-of-scaling-up-syringe-service-provision-among-people-who-inject-drugs-in-perry-county-kentucky/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/modelling-the-impact-of-prevention-and-treatment-interventions-on-hiv-and-hepatitis-c-virus-transmission-among-people-who-inject-drugs-in-nairobi/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/sexualised-drug-use-and-co-occurring-high-risk-behaviours-among-gay-and-bisexual-men-living-with-hiv-hepatitis-c-co-infection-in-melbourne-australia/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/mobile-community-based-liver-health-assessment-in-underserved-populations-the-hepcare-project/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/estimation-of-the-number-of-people-who-inject-drugs-and-live-with-hiv-and-viral-hepatitis-co-infection-in-ukraine/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/changes-in-drug-and-alcohol-use-and-injection-risk-behaviours-among-people-who-inject-drugs-during-and-following-hcv-direct-acting-antiviral-treatment-the-simplify-and-d3feat-studies/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/preliminary-analysis-of-the-superdot-c-study-a-cluster-randomised-controlled-trial-of-pharmacy-led-versus-conventional-treatment-for-hcv-positive-patients-receiving-daily-opioid-substitution-therapy/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/estimation-of-the-cascade-of-hcv-testing-care-and-treatment-among-active-pwid-who-attend-four-harm-reduction-centers-in-catalonia-hepcdetect-ii-study/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/excellent-efficacy-of-direct-acting-antivirals-daas-for-the-treatment-of-hepatitis-c-among-people-who-inject-drugs-pwid-experience-from-a-large-expertized-greek-center/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/universal-on-site-hcv-rna-screening-is-warranted-among-active-pwid-who-attend-harm-reduction-centres-in-catalonia-spain-hepcdetect-ii-study/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/barriers-and-facilitators-of-hepatitis-c-hcv-treatment-initiation-among-people-who-inject-drugs-in-the-era-of-new-direct-acting-antivirals/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/do-national-hcv-policies-in-the-eu-address-treatment-and-care-for-people-who-inject-drugs/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/factors-associated-with-hcv-testing-among-people-who-inject-drugs-in-an-urban-setting-in-vietnam/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/cost-effectiveness-analysis-of-testing-strategies-for-diagnosing-hepatitis-c-virus-infection-in-pwids-in-resource-constrained-countries/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/interventions-to-increase-testing-linkage-to-care-and-treatment-of-hepatitis-c-virus-hcv-among-people-in-prisons-a-systematic-review/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/hepatitis-c-knowledge-and-training-among-people-working-in-the-alcohol-and-other-drugs-sector/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/modelling-the-impact-of-prevention-and-treatment-interventions-on-hiv-and-hepatitis-c-virus-transmission-among-people-who-inject-drugs-in-nairobi/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/cost-effectiveness-of-scaling-up-syringe-service-provision-among-people-who-inject-drugs-in-perry-county-kentucky/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/sexualised-drug-use-and-co-occurring-high-risk-behaviours-among-gay-and-bisexual-men-living-with-hiv-hepatitis-c-co-infection-in-melbourne-australia/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/strenghtening-patients-pathway-for-a-better-hepatitis-c-care-in-most-vulnerable-populations-the-hcv-parcours-projet-in-ile-de-france-idf/ 2021-01-20T02:58:10+00:00 https://www.inhsu.org/resource/knowledge-around-direct-acting-antiviral-therapies-and-willingness-to-undergo-hcv-treatment-among-rural-appalachian-opioid-users/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/demographic-and-socioeconomic-differences-among-hepatitis-c-patients-seen-in-community-and-specialist-outpatient-care-settings-in-new-brunswick-canada/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/the-association-between-delayed-return-and-transfer-experience-among-methadone-maintenance-treatment-participants-in-guangdong-china-a-retrospective-cohort-study/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/language-matters-the-development-of-a-resource-to-improve-treatment-access-and-reduce-stigma-in-drug-and-alcohol-treatment-settings-through-a-community-partnership-model/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-wanted-yet-not-received-barriers-to-receiving-hcv-treatment-among-people-who-inject-drugs/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/the-cost-effectiveness-of-community-pharmacy-dry-blood-spot-screening-for-hepatitis-c-in-a-rural-population-of-people-who-inject-drugs/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-hcv-screening-in-people-who-use-drugs-pwud-what-your-patients-want-you-to-know/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/hcv-elimination-in-dutch-pwud-the-5-steps-of-the-national-hepatitis-plan/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/health-promotion-a-continuing-role-for-peer-support-worker-in-drug-health-service-liver-clinic/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/a-mixed-method-evaluation-of-nhs-taysides-injecting-equipment-provision-services/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/integration-of-hcv-care-in-harm-reduction-settings/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/hepatitis-c-screening-program-in-infants-born-to-high-risk-mothers/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/hcv-infected-youth-characteristics-and-representation-in-the-canhepc-retrospective-national-registry/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/new-questions-about-hcv-from-a-new-generation/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/assessment-of-hepatitis-c-treatment-access-barriers-among-pwid-in-the-catalan-substance-abuse-treatment-network/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/changes-in-quality-of-life-scores-before-and-after-hepatitis-c-treatment-by-inner-city-primary-teams-in-inner-city-community-health-clinics/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/lost-opportunities-and-potential-of-hcv-test-and-treatment-among-people-who-inject-drugs-in-ukraine/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/hcv-cascade-of-care-at-an-integrated-community-facility-for-pwid/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/limited-hepatitis-c-treatment-and-barriers-for-injection-drugusers-in-chinese-methadone-treatment-clinics-comprehensive-hepatiti-c-care-is-needed/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/attitude-of-staff-regarding-integrated-hepatitis-c-treatment-at-eight-harm-reducation-centers-in-georgia/ 2021-01-20T02:58:18+00:00 https://www.inhsu.org/resource/daily-dosing-of-direct-acting-antivirals-daa-from-a-public-opioid-substitution-treatment-ost-program-for-marginalised-clients-in-kings-cross-sydney/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/community-outreach-events-engaging-the-disengaged/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/engaging-pwid-in-community-based-treatment-and-care-using-a-nurse-led-social-network-model/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/a-multi-sectoral-model-to-support-hepatitis-c-testing-and-treatment-access-among-people-who-inject-drugs-in-hanoi-vietnam/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/indigenous-led-hepatitis-c-treatment-model-to-achieve-elimination-in-big-river-first-nation/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/integrating-hepatitis-c-care-for-at-risk-groups-findings-from-a-multi-centre-observational-study-in-primary-and-community-care/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/preliminary-analysis-of-the-prime-study-a-randomized-controlled-trial-comparing-the-hepatitis-c-care-cascade-in-primary-care-vs-tertiary-care/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/straight-to-the-point-lessons-from-the-rapid-ec-study-a-point-of-care-hepatitis-c-testing-pilot-in-needle-and-syringe-programs-targeted-to-people-who-inject-drugs-in-australia/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/the-results-of-hiv-and-hcv-prevention-program-among-pwid-in-ukraine/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/a-cost-effective-strategy-to-reach-the-who-hepatitis-c-virus-hcv-elimination-target-in-men-who-have-sex-with-men-in-the-uk-a-90-decrease-in-hepatitis-c-incidence-by-2030/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/meaningful-involvenment-of-indonesian-drugs-user-network-in-respond-and-availability-hcv-treatment-access-in-indonesia/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/furthering-the-hepatitis-c-diagnosis-process-to-easy-access-and-comprehensive-coverage/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/models-of-care-from-patient-to-organizer-of-community-testing/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/user-driven-hcv-clinic-on-4-wheels/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/experience-and-outcomes-of-a-high-volume-homeless-health-center-based-hcv-treatment-program-in-boston/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/w3-framework-understanding-the-role-and-quality-of-peer-led-programs-by-people-who-inject-drugs-in-a-national-hepatitis-c-response/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/the-kombi-clinic-driving-out-hep-c-in-south-east-queensland-disenfranchised-communities/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/hepatitis-c-screening-and-linkage-to-care-at-four-new-york-city-syringe-exchange-programs/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/treating-people-where-they-are-lessons-from-outreach-hcv-treatment-for-networks-of-people-with-recent-injecting-drug-use-in-victoria-canada/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/building-bridges-to-eliminate-hcv-in-pwid-knowledge-and-planned-performance-change-among-hcv-treaters-and-addiction-services-providers-engaged-in-a-pilot-education-initiative/ 2021-01-20T02:58:26+00:00 https://www.inhsu.org/resource/project-intacct-integrated-community-hepatitis-c-treatment/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/towards-the-microelimination-of-hcv-in-tayside-scotland/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/hepatitis-c-cascade-of-care-among-people-who-inject-drugs-in-poland-gaps-both-at-testing-and-linkage-to-care-levels/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/hepatitis-c-nurse-as-a-case-manager-in-people-who-inject-drugs/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/positively-hep-a-multidisciplinary-incentivised-hepatitis-c-program-for-disadvantaged-communities/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/screening-for-hcv-with-dried-blood-spot-test-in-active-drug-users-evaluation-of-magnitude-before-intervention/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-and-linkage-to-care-in-patients-with-mental-illness-who-use-drugs-a-core-team-network/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/model-addressing-hepatitis-c-an-epidemic-that-impacts-pwid/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/improving-access-to-hepatitis-c-treatment-for-people-currently-injecting-drugs-a-sexual-health-clinic-model-of-care/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/hospital-zero-hepatitis-for-drug-users-easy-and-useful/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/hcv-from-screening-to-cure-a-broad-partnership-within-a-tough-background/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/a-community-based-hepatitis-c-treatment-programme-in-edinburgh-scotland/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/the-swiss-hepatitis-c-association-shca/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/pharmacological-monitoring-of-participants-undergoing-daatreatment-for-hepatitis-c-infection-in-nhs-tayside-concomitant-medications-of-people-who-inject-drugs-participating-in-the-superdot-c-trial/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/treatment-of-hepatitis-c-in-a-community-based-opioid-substitution-ost-clinic/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/integration-of-onsite-behavioral-health-consultation-and-hepatitis-c-treatment-in-a-federally-qualified-health-center-network-philadelphia-pa/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/outcomes-for-chronic-viral-hepatitis-treatment-and-control-10-years-data-from-the-first-harm-reduction-approach-ost-center-from-bucharest/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/prioritised-annual-hepatitis-c-testing-drives-in-drug-recovery-services-show-acceptability-and-effectiveness-of-testing/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/combined-drug-recovery-and-hepatitis-c-treatment-clinic-leads-to-more-effective-engagement-than-traditional-care-model/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/rural-environment-breaking-distances-to-care-go-towards-to-bring-to/ 2021-01-20T02:58:34+00:00 https://www.inhsu.org/resource/c-be-be-your-rights-to-end-once-and-for-all-with-hepatitis-c-among-drug-users-an-example-of-community-mobilization/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/introduction-of-a-combined-ost-advanced-fibrosis-community-clinic-results-in-high-engagement-with-a-cohort-of-patients-with-previous-non-attendance-at-hospital-appointments/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/seek-and-treat-a-dublin-community-based-peer-facilitated-screening-project/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/video-observer-treatment-for-hepatitis-c-patients-improving-adherence-and-outcomes-hepcare-europe/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/special-concern-and-strategy-for-optimizing-cascade-care-among-prisoners-the-hcv-parcours-project-in-ile-de-france-idf/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/expanding-access-to-hepatitis-c-care-in-community-and-correctional-settings-via-non-traditional-models-in-saskatchewan-canada/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/a-pilot-program-of-screening-and-linkage-to-care-for-hepatitis-c-in-a-greek-prison/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/expertc-a-pilot-in-building-a-care-cascade-from-the-ground-up/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/treatment-of-hepatitis-c-in-the-homeless-drug-using-population-an-innovative-shared-care-approach-removing-barriers-to-access/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/the-development-of-a-collaborative-model-to-optimise-antiviral-treatment-in-community-drug-services/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/identification-assessment-and-management-of-hepatitis-c-virus-hcv-and-delivering-direct-acting-antiviral-daa-treatment-in-outreach-setting/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/re-engaging-pwid-to-hepatitis-c-care-and-treatment-in-the-north-east-of-scotland/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/evaluation-of-an-integrated-nurse-model-of-care-providing-hepatitis-c-treatment-to-people-attending-homeless-services-in-melbourne-australia/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/feasibility-of-a-global-out-of-wall-assessment-of-hepatitis-c-liver-disease-in-drug-center-service/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/c-change-philadelphias-plan-to-eliminate-hepatitis-c-among-people-who-use-injection-drugs/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/working-collaboratively-to-increase-hcv-testing-and-treatment/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/test-and-treat-6-years-of-hcv-rapid-testing-among-drug-users-in-the-bayonne-area-france/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/peer-led-harm-reduction-service-delivers-significantly-better-outcomes-in-hepatitis-c-prevention-and-treatment/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/evaluation-of-an-hcv-awareness-raising-and-testing-intervention-in-pwid/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/hepfriend-peer-support-and-community-engagement-in-underserved-populations-with-hepatitis-c-in-the-uk-ireland-romania-and-spain-as-part-of-the-hepcare-programme/ 2021-01-20T02:58:42+00:00 https://www.inhsu.org/resource/pursuing-micro-elimination-of-hcv-among-pwid-in-an-ost-clinic-in-southern-switzerland-the-implementation-of-daa-therapy-through-an-interdisciplinary-approach/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/liver-health-event-de-stigmatizing-hepatitis-c-to-enhance-screening-and-linkage-to-care-in-indigenous-communities/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/from-analysis-to-social-innovation-the-aging-process-of-people-who-use-drugs-in-opioid-substitution-treatment-development-of-innovative-care-scenarios-and-training-programs-for-social-and-health-pro/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/liberating-medeco-inala-from-hep-c-a-study-of-micro-elimination-in-primary-care/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/health-prevention-delegate-visiting-general-practitioners-and-pharmacists-in-the-pyrenees-atlantiques-area-france/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/implementation-of-routine-hiv-hcv-screening-and-linkage-to-care-in-the-idea-exchange-miami-fl/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/an-onsite-primary-care-based-approach-allows-rapid-reduction-of-hepatitis-c-prevalence-in-prison-a-case-study-from-canberra-australia/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/recap-an-interprofessional-comprehensive-community-based-care-clinic-for-the-management-of-hepatitis-c-positive-and-at-risk-individuals-in-saint-john-new-brunswick-canada/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/accelerating-the-hepatitis-c-care-cascade-for-patients-with-substance-use/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/chronic-hepatitis-c-eradication-model-through-primary-care-in-british-columbia-canada/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/hepatitis-c-care-in-an-opioid-substitution-treatment-unit/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/a-responsive-model-of-care-utilizing-a-collaborative-nurse-practitioner-and-peer-based-model-of-care-to-meet-the-needs-of-injecting-drug-users/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/the-cascade-of-hcv-care-among-people-who-inject-drugs-in-a-norwegian-low-threshold-setting-increasing-treatment-uptake/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/a-community-based-model-of-peer-led-anonymous-rapid-hepatitis-c-hcv-testing-for-people-who-inject-drugs-pwids-in-mauritius/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/treatment-of-hepatitis-c-in-a-cohort-of-former-and-current-injecting-drug-users-in-nairobi-kenya/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/the-road-to-hepatitis-c-elimination-a-change-in-care-pathway-increases-access-to-hepatitis-c-treatment-for-people-on-opiate-substitution-therapy/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/liver-health-event-de-stigmatizing-hepatitis-c-to-enhance-screening-and-linkage-to-care-in-indigenous-communities/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/pursuing-micro-elimination-of-hcv-among-pwid-in-an-ost-clinic-in-southern-switzerland-the-implementation-of-daa-therapy-through-an-interdisciplinary-approach/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/from-analysis-to-social-innovation-the-aging-process-of-people-who-use-drugs-in-opioid-substitution-treatment-development-of-innovative-care-scenarios-and-training-programs-for-social-and-health-pro/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/community-led-hepatitis-c-treatment-amongst-people-with-active-injection-drug-use-in-an-indigenous-community-in-canada/ 2021-01-20T02:58:50+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-testing-liver-disease-assessment-and-treatment-uptake-among-people-who-inject-drugs-pre-and-post-universal-access-to-direct-acting-antiviral-treatment-in-australia-the-liverlife-s/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/drug-and-alcohol-use-during-hcv-treatment-in-the-real-life-among-pwid-in-southern-switzerland/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/reinfection-and-retreatment-attitudes-among-prisoner-participants-from-the-australian-stop-c-study/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/client-and-staff-perspectives-on-point-of-care-hepatitis-c-testing-for-people-attending-needle-syringe-programs/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/conceptualising-access-in-the-daa-era-applying-the-candidacy-framework-to-inform-research-and-practice-in-hcv-care-for-people-who-use-drugs/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/rural-risk-environment-for-hepatitis-c-among-young-adults-who-use-opioids-in-appalachian-kentucky/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/hav-hbv-hcvprevalence-risk-factors-and-hav-hbv-vaccine-uptake-among-at-risk-men-who-have-sex-with-men-msm/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/towards-eliminating-viral-hepatitis-examining-the-productive-capacity-and-constitutive-effects-of-global-policy-on-hepatitis-c-elimination/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/snapshot-of-frontline-perspectives-on-hepatitis-c-services-for-most-at-risk-populations-in-middle-income-countries-informing-progress-and-response-toward-2030-elimination-targets/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/past-experiences-of-stigma-shaping-present-perceptions-of-healthcare-among-people-who-inject-drugs-living-with-hepatitis-c/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/the-national-stigma-indicator-project-key-findings-and-lessons-regarding-people-living-with-hcv-and-people-who-inject-drugs/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/increase-in-hcv-prevalence-among-people-who-inject-drugs-in-ukraine/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/care-beyond-the-virus-engaging-the-most-marginalised-in-hepatitis-c-care/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/improving-pwid-hepatitis-c-care-cascade-through-electronic-health-engagement/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/extending-the-criteria-for-chronic-hepatitis-c-chc-treatment-with-direct-acting-antivirals-daas-in-greece-best-benefit-in-linkage-to-care-for-patients-who-inject-drugs-pwids/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/hcv-micro-elimination-in-a-real-world-setting-at-substitution-programs-in-athens-greece/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/health-care-related-stigma-among-people-who-inject-drugs-in-new-york-city/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/barriers-to-hepatitis-c-treatment-persist-from-the-interferon-era/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/end-hepc-nm-a-collaborative-approach-towards-hepatitis-c-elimination-in-a-resource-scarce-environment/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/glecaprevir-pibrentasvir-achieves-high-svr-rates-amongst-people-who-use-drugs-results-from-a-real-world-cohort/ 2021-01-20T02:58:58+00:00 https://www.inhsu.org/resource/nurse-led-community-based-hepatitis-c-treatment-is-feasible-and-effective-among-people-who-inject-drugs-and-their-injecting-network-the-hcv-treatment-and-prevention-tap-study/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/decreasing-hepatitis-c-incidence-and-prevalence-through-enhancing-hcv-care-and-treatment-among-hiv-co-infected-individuals-the-co-ec-study-outcomes/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/accessible-care-intervention-for-engaging-people-who-inject-illicit-drugs-in-hepatitis-c-virus-care-preliminary-results-from-a-randomized-clinical-trial/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/identification-of-hcv-and-linkage-to-care-from-a-detoxification-unit-a-novel-strategy-for-hcv-micro-elimination-431/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/spontaneous-clearance-of-hepatitis-c-virus-in-a-cohort-of-patients-enrolled-in-a-harm-reduction-clinic-in-new-brunswick-canada-2014-2018/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/recent-opioid-agonist-therapy-and-hepatitis-c-virus-treatment-uptake-among-people-who-inject-drugs-with-chronic-hepatitis-c-infection-in-a-population-based-data-linkage-study/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/svr12-outcomes-in-chronic-hcv-infected-pwid-who-are-non-compliant-with-recommended-treatment-regimens/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/does-injecting-behaviour-change-following-direct-acting-antiviral-hepatitis-c-therapy-in-persons-who-inject-drugs/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/rare-hcv-re-infection-after-daa-treatment-in-an-integrated-all-under-one-roof-care-setting/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/task-shifting-in-hcv-testing-and-research-improving-knowledge-of-hcv-status-through-a-peer-outreach-hepatitis-c-point-of-care-project-in-toronto-canada/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/sustained-virological-response-to-hcv-treatment-with-direct-acting-antivirals-in-people-who-inject-drugs-pwid-and-non-pwid-results-of-a-national-comparative-survey-in-slovenia/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/real-world-outcomes-in-patients-with-chronic-hepatitis-c-virus-infection-with-opioid-substitution-therapy-mental-disorders-or-alcohol-use-disorder-treated-with-glecaprevir-pibrentasvir-data-from-th/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/saving-lives-and-facilitating-access-to-health-care-12-months-of-treating-hepatitis-c-in-a-medically-supervised-injecting-room-in-melbourne/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/characterization-of-patients-in-canada-with-chronic-hcv-infection-initiating-daa-therapy-based-on-risk-for-hcv-transmission-and-response-to-treatment-the-real-world-c-respect-study/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/real-world-efficacy-of-salvage-therapies-for-the-treatment-of-chronic-hepatitis-c-virus-infection-in-treatment-experienced-people-who-inject-drugs-pwid/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/low-rate-of-reinfection-among-a-cohort-of-people-who-inject-drugs-successfully-treated-for-hepatitis-c-virus-infection-within-a-multidisciplinary-program/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/comparing-adherence-to-once-daily-and-twice-daily-daa-therapy-among-people-with-recent-injection-drug-use-or-current-opioid-substitution-therapy-the-simplify-and-d3feat-studies/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/treatment-adherence-and-comletion-efficacy-and-safety-of-daas-in-chronic-hcv-patients-under-opioid-substitution-programs/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/efficacy-of-sofosbuvir-velpatasvir-ribavirin-combination-in-cirrhotic-genotype-3-hcv-patients-receiving-opioid-substitution-therapy-previously-failures-to-sofosbuvir-daclatasvir-ribavirin/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/drug-use-and-reinfection-during-and-following-hcv-treatment-with-elbasvir-grazoprevir-ebr-gzr-among-patients-receiving-opioid-agonist-therapy-final-results-from-the-co-star-study/ 2021-01-20T02:59:06+00:00 https://www.inhsu.org/resource/actively-injecting-pwid-who-use-stimulants-can-be-successfully-treated-for-hcv-infection/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/drug-user-healthcare-delivered-onsite-at-a-syringe-exchange-hcv-mat-and-prep/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/liver-fibrosis-stage-in-hcv-positive-non-treated-patients-in-an-opioid-substitution-therapy-program/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/an-innovative-model-for-linkage-to-care-of-pwid-with-hcv-infection-in-italy/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/057-feasibility-of-rapid-hepatitis-c-point-of-care-rna-testing-and-treatment-at-an-integrated-supervised-consumption-site-in-toronto-canada/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/055-effect-of-a-single-day-investigation-for-hcv-infection-on-treatment-initiation-among-pwid-before-and-after-universal-access-to-direct-acting-antivirals/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/hcv-support-groups-do-they-still-have-a-role-in-the-daa-era/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/real-world-outcomes-from-people-who-use-drugs-with-chronic-hepatitis-c-virus-infection-treated-with-glecaprevir-pibrentasvir-a-pooled-analysis-of-post-marketing-observational-studies/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/time-to-detection-of-hepatitis-c-virus-infection-with-the-xpert-hcv-viral-load-finger-stick-point-of-care-assay-facilitating-a-more-rapid-time-to-diagnosis/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/enhanced-self-efficacy-for-hcv-management-among-people-participating-an-hcv-education-program-focused-on-drug-and-alcohol-and-primary-care-settings/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-reinfection-following-antiviral-treatment-among-people-who-use-or-inject-drugs-a-systematic-review-and-meta-analysis/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/influence-of-social-determinants-of-health-and-substance-use-characteristics-on-persons-who-use-drugs-pursuit-of-care-for-hepatitis-c-virus-infection/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/hcv-treatment-adherence-among-people-who-inject-drugs-pwid/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/real-world-treatment-data-from-a-needle-exchange-with-a-high-prevalence-of-hcv-and-amphetamine-use/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/hcv-seek-test-and-rapid-treatment-hcv-strt-for-young-people-who-inject-drugs-with-hepatitis-c-description-of-model-and-baseline-characteristics/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/hcv-reinfection-not-associated-with-oat-engagement-drug-use-or-sexual-risk-in-persons-with-opioid-use-disorder-and-injection-drug-use-data-from-the-anchor-study/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/dispensing-mode-and-hepatitis-c-direct-acting-antiviral-treatment-completion/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/hcv-among-cirrhotic-people-who-use-inject-drugs-pwid-response-to-therapy-and-long-term-follow-up/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/multidisciplinary-care-and-the-four-legged-chair-the-addiction-leg/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/054-morbidity-and-mortality-in-hcv-infected-people-who-use-drugs-pwud-beyond-the-svr12/ 2021-01-20T02:59:14+00:00 https://www.inhsu.org/resource/hcv-microelimination-%ce%b5nhanced-by-a-network-connecting-all-detoxification-and-substitution-programs-with-an-expertized-hepatology-clinic-in-northen-greece/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/challenges-in-delivery-of-point-of-care-testing-for-hcv-rna-in-a-mobile-health-service-for-people-who-inject-drugs-pwid/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/very-late-relapse-of-chronic-hepatitis-c-treated-with-ldv-sof/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/the-road-to-hepatitis-c-virus-hcv-elimination-re-infections-after-sustained-viral-response-svr-why-we-must-retest-and-offer-retreatment/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/058-working-towards-micro-elimination-of-hcv-in-pwid-a-direct-observed-therapy-vs-fortnightly-collection-study-for-hcv-treatment-advance-hcv-study/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/interim-results-of-an-ongoing-project-to-eliminate-chronic-hepatitis-c-in-pwid-with-ongoing-intravenous-drug-use-and-a-high-risk-of-non-adherence-to-direct-acting-antivirals-in-vienna/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/interim-results-of-an-austrian-hcv-microelimination-project-to-increase-screening-and-linkage-to-care-in-pwid-in-vienna/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/a-novel-hepatitis-c-micro-elimination-model-in-a-large-healthcare-for-the-homeless-organization/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/high-rates-of-opioid-overdose-and-witnessed-overdose-in-pwid-receiving-hcv-treatment-data-from-the-anchor-study/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/high-uptake-of-collocated-opioid-agonist-therapy-with-daa-is-associated-with-reduced-risks-and-improved-svr-in-people-with-active-injection-drug-use-data-from-the-anchor-study/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/evaluating-treatment-as-prevention-among-people-who-inject-drugs-in-dundee-for-hcv-erapid-hcv/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/targeted-testing-pathways-improve-hepatitis-c-diagnosis-rates/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/maximising-adherence-to-direct-acting-antivirals-among-street-based-and-marginalised-clients-the-results-of-daily-dosing/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/the-challenge-of-follow-up-hepatocellular-carcinoma-surveillance-in-marginalized-patients-with-cirrhosis-treated-for-hcv-in-a-low-threshold-primary-health-care-setting/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/clinical-effectiveness-of-pharmacy-led-versus-conventionally-delivered-antiviral-treatment-for-hepatitis-c-in-patients-receiving-opioid-substitution-therapy-a-pragmatic-cluster-randomised-trial/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/patterns-and-correlates-of-cigarette-smoking-among-people-who-inject-drugs-receiving-treatment-for-hepatitis-c/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/risk-behaviours-and-prevalence-of-blood-borne-infections-in-young-people-seeking-treatment-or-advice-for-drug-use-the-potential-of-dried-blood-spots/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/patient-reported-experience-and-outcome-of-hepatitis-c-treatment-in-people-who-inject-drugs-or-receiving-opiate-substitution-therapy-a-peer-initiated-survey-in-denmark/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/time-to-treatment-disfavors-hcv-patients-with-hiv-co-infection/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/prevalence-of-alcohol-and-substance-use-in-hiv-hcv-co-infected-patients-receiving-antiretrovirals/ 2021-01-20T02:59:22+00:00 https://www.inhsu.org/resource/making-oraquick-quicker-a-hepatitis-c-point-of-care-test-reduced-to-five-minutes-for-viremic-individuals/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/recent-abstinence-at-the-moment-to-initiate-hcv-treatment-is-no-guarantee-to-avoid-hcv-reinfections/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/factors-contributing-to-hcv-treatment-failure-and-successful-retreatment-in-people-who-use-drugs/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/knowledge-synthesis-of-patient-and-provider-perceived-barriers-and-facilitators-to-hepatitis-c-hcv-treatment-among-human-immunodeficiency-virus-hiv-coinfected-populations-in-canada/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/diversity-of-detention-patterns-among-people-who-inject-drugs-and-the-associated-risk-with-incident-hepatitis-c-virus-hcv-infection-implications-for-hcv-prevention/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/hepatitis-c-testing-and-access-to-care-among-people-who-inject-psychoactive-drugs-in-england-wales-and-northern-ireland-insights-from-2017-national-survey-data/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/the-association-between-homelessness-and-hepatitis-c-exposure-among-11101-people-who-inject-drugs-in-england-wales-and-northern-ireland-a-cross-sectional-study/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/early-impact-of-direct-acting-antivirals-on-chronic-hepatitis-c-prevalence-among-people-who-inject-drugs-in-england-real-world-data-2011-2017/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/baseline-prevalence-and-predictors-of-hiv-hcv-infection-among-persons-who-inject-drugs-accessing-a-syringe-services-program-miami-fl/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/injection-drug-use-injection-risk-and-hiv-hcv-status-among-people-accessing-a-syringe-service-program-a-latent-class-analysis/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/007-inconsistencies-in-methodology-reporting-and-subjective-description-of-hepatitis-c-virus-reinfection-rates-among-people-who-inject-drugs-potential-contribution-to-stigma-and-discrimination/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/barriers-of-linkage-to-hepatitis-c-care-among-people-who-inject-drugs-in-georgia/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/geographic-cascade-of-hcv-care-a-tool-for-targeted-interventions-and-program-evaluation/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/evaluation-of-hcv-rna-testing-from-finger-stick-capillary-dried-blood-spot-and-venepunture-collected-samples-a-cohort-study/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/hcv-diagnosis-and-treatment-impact-of-knowledge-of-hcv-status-on-behaviour-of-people-who-inject-drugs-a-service-evaluation-the-hooked-c-project/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/recent-abstinence-at-the-moment-to-initiate-hcv-treatment-is-no-guarantee-to-avoid-hcv-reinfections/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/making-oraquick-quicker-a-hepatitis-c-point-of-care-test-reduced-to-five-minutes-for-viremic-individuals/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/factors-contributing-to-hcv-treatment-failure-and-successful-retreatment-in-people-who-use-drugs/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/predictors-of-hepatitis-c-virus-treatment-outcomes-in-a-harm-reduction-focused-primary-care-program-in-new-york-city/ 2021-01-20T02:59:30+00:00 https://www.inhsu.org/resource/an-intervention-to-improve-hcv-testing-linkage-to-care-and-treatment-among-people-who-use-drugs-in-tehran-iran-the-enhance-study/ 2021-01-20T02:59:31+00:00 https://www.inhsu.org/resource/risk-of-hcv-reinfection-and-associated-patterns-of-behaviour-among-men-who-inject-drugs-or-who-have-sex-with-men-in-canada/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/chronic-medical-diseases-and-healthcare-utilization-in-people-who-currently-inject-drugs-pcid-with-hepatitis-c-hcv-in-new-york-city/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/utilization-of-point-of-care-hepatitis-c-testing-on-priority-populations-in-an-outreach-setting/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/towards-optimising-care-and-prevention-for-people-who-inject-drugs-and-living-with-hiv-and-viral-hepatitis-in-melbourne-australia-evaluation-of-an-integrated-hiv-and-homelessness-nursing-service/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/risk-behaviours-following-hepatitis-c-treatment-among-gay-and-bisexual-men-living-with-hiv-in-melbourne-australia/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/hepatitis-b-immunity-and-susceptability-among-people-living-with-hiv-and-hepatitis-c-co-infection-in-melbourne-australia/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/015-community-based-point-of-care-testing-and-treatment-for-people-who-inject-drugs-in-myanmar/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/a-network-of-people-who-inject-drugs-successfully-produced-a-state-wide-authenticated-hcv-prevalence-data-among-pwids-and-their-spouses-perhaps-still-the-only-state-data-ever-produced/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/association-between-short-term-housing-patterns-and-hepatitis-c-acquisition-findings-from-a-cohort-of-people-who-inject-drugs-in-montreal-canada/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/modelling-the-impact-of-prevention-and-treatment-interventions-for-people-who-inject-drugs-in-dar-es-salaam-tanzania/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/re-engagement-in-care-for-hepatitis-c-in-the-trap-hepc-program-every-patient-deserves-a-second-chance/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/enhancing-linkage-to-hepatitis-c-care-upon-release-from-canadian-provincial-prisons-the-population-level-impact-on-hepatitis-c-transmission-among-people-who-inject-drugs-in-montreal/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/hepatitis-c-screening-and-treatment-within-an-opioid-treatment-program-current-challenges-and-potential-solutions/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/integrated-harm-reduction-programming-syringe-service-programs-and-hiv-hcv-testing/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/011-detecting-hepatitis-c-virus-transmission-clusters-using-remnant-serum-specimens-from-key-affected-populations-tested-in-public-health-settings/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/a-one-stop-community-based-approach-for-hcv-screening-diagnosis-and-treatment-among-people-who-inject-drugs-in-iran-the-rostam-study/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/disparity-among-marginalized-patients-in-the-hepatitis-c-cascade-of-care-in-a-specialized-clinic/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/short-term-cheque-effects-on-drug-consumption-behaviour-and-their-association-with-determinants-of-hcv-risk-among-people-who-inject-drugs/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/the-hepatitis-c-virus-hcv-cascade-of-care-in-the-new-york-city-nyc-jail-system/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/study-of-compliance-in-iv-drug-users-with-hepatitis-c-10-years-follow-up-data-from-a-university-hospital-in-greece/ 2021-01-20T02:59:38+00:00 https://www.inhsu.org/resource/most-at-risk-populations-and-healthcare-workers-perspectives-on-existing-services-for-hepatitis-c-care-and-support-in-malaysia/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/defining-dosing-related-tapering-characteristics-to-decrease-concurrent-heroin-use-a-retrospective-cohort-study-of-methadone-maintenance-treatment-participants-in-guangdong-china/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/psychosocial-predictors-of-risk-of-hepatitis-c-hcv-reinfection-in-people-who-inject-drugs-on-hcv-treatment/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/novel-hcv-screening-strategies-for-hard-to-reach-populations-are-they-cost-effective/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/association-between-prescription-opioids-and-hepatitis-c-virus-seroconversion-among-people-who-use-injection-drugs-in-british-columbia/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-reinfection-after-successful-treatment-with-direct-acting-antiviral-therapy-in-canada/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/hcv-among-people-who-inject-drugs-in-france-acting-on-risk-environment-in-an-evolving-crisis/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/pilot-testing-take-charge-get-cured-with-methadone-patients-a-mhealth-tool-addressing-hcv-treatment-initiation/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/risky-behavior-and-hiv-hcv-knowledge-of-women-commercial-sex-workers-wcsws-and-injecting-drug-users-idus-in-rajshahi-city-of-bangladesh/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/increasing-number-of-providers-treating-hepatitis-c-after-direct-acting-antivirals-in-the-united-states-implications-for-treatment-access/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/hiv-percentage-of-all-types-of-hepatitis-virus-in-ivdu-users-among-the-population-of-hellas/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/clinical-and-epidemiological-characteristics-of-chc-access-to-treatment-with-daas/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/barriers-and-facilitators-to-hepatitis-c-treatment-using-director-acting-antivirals-among-people-who-inject-drugs-in-san-francisco-california/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/vulnerability-to-hiv-infection-among-female-drug-users-in-kathmandu-nepal/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/the-sexual-partners-of-people-who-inject-drugs-in-ukraine-is-the-next-target-of-the-hiv-epidemic-if-no-prevention-applied/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/factors-associated-with-overdose-among-people-who-inject-drugs-in-ukraine/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/hiv-and-hcv-among-people-who-inject-drugs-in-ukraine-a-stabilization-or-a-calm-before-the-storm/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/disparities-in-hepatitis-c-virus-hcv-care-across-quebecs-provincial-prisons-implications-for-hcv-micro-elimination/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/an-international-systematic-review-of-methadone-and-buprenorphine-doses-used-in-the-treatment-of-opioid-use-disorder/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/factors-associated-with-the-improvement-of-family-relationships-among-methadone-maintenance-treatment-clients-a-longitudinal-analysis-of-register-data-from-15-clinics-in-guangdong-china/ 2021-01-20T02:59:46+00:00 https://www.inhsu.org/resource/drug-use-habits-overdose-experience-and-infectious-disease-risk-behaviors-among-participants-in-an-urban-syringe-exchange-program/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/late-presentation-of-chronic-hepatitis-b-and-c-virus-in-people-who-inject-drugs-in-spain-despite-unrestricted-access-to-hbv-and-hcv-therapy/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/opportunities-for-engaging-patients-in-care-along-the-hepatitis-c-cascade-of-care/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/a-global-investment-framework-for-hepatitis-c-elimination/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/hepatitis-c-antibody-testing-trend-pre-and-post-universal-access-to-direct-acting-antivirals-in-australia-segmented-regression-of-primary-care-clinic-data/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/the-impact-of-community-based-rapid-point-of-care-testing-on-enhancing-uptake-of-hepatitis-c-treatment-for-people-who-inject-drugs-in-needle-and-syringe-services/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/014-what-is-the-optimal-hcv-elimination-strategy-among-pwid-in-a-middle-income-high-burden-setting-a-modeling-and-economic-analysis-in-tijuana-mexico/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/cost-effectiveness-of-universal-hepatitis-c-virus-screening-of-pregnant-women-in-the-united-states/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/comparing-trial-designs-for-hcv-treatment-as-prevention-an-empirical-evaluation/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/finding-the-starting-point-toward-hepatitis-c-elimination-identifying-known-prevalent-hepatitis-c-cases-in-southern-new-brunswick-canada/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/hepatitis-c-related-mortality-in-a-cohort-of-drug-users-in-flanders/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/the-evolving-hepatitis-c-care-cascade-in-a-real-world-setting-results-for-the-period-2003-2017-from-free-clinic-antwerp/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/the-cedar-hcv-blanket-program-barriers-and-facilitators-of-hepatitis-c-treatment-uptake-among-indigenous-people-who-use-drugs-in-bc-canada/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/featuring-screening-hepatitis-c-and-social-network-many-ex-drug-users-among-alcoolic-population-screening-hepatitis-c-on-a-facebook-group-called-mois-sobre/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/operationalizing-the-risk-environment-spatial-distribution-of-people-who-inject-drugs-and-hotspots-of-social-injecting-activity-in-montreal-canada/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/using-hepatitis-c-surveillance-data-to-profile-hepatitis-c-care-at-substance-use-treatment-facilities-new-york-city-2017-2018/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/ageing-with-addiction-describing-health-conditions-of-younger-and-older-drug-users-in-switzerland/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/018-willingness-to-access-community-based-hepatitis-c-and-hiv-testing-centres-among-injecting-drug-users-in-lagos-nigeria/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/the-scottish-experience-reduction-in-the-population-prevalence-of-chronic-hcv-among-people-who-inject-drugs-associated-with-major-scale-up-of-direct-acting-antiviral-therapy-in-community-drug-service/ 2021-01-20T02:59:54+00:00 https://www.inhsu.org/resource/a-threshold-analysis-of-the-cost-effectiveness-of-hepatitis-c-testing-in-emergency-departments-in-the-u/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/a-cost-effectiveness-analysis-of-an-intervention-to-increase-linkage-to-care-of-hcv-infected-patients-on-opioid-substitution-therapy-heplink-ireland/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/the-cost-effectiveness-of-an-hcv-outreach-intervention-for-at-risk-populations-in-london-uk/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/current-practices-of-screening-hepatitis-c-infection-in-an-integrated-response-center-for-additive-and-dependence-behaviours/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/spontaneous-remission-in-hcv-exposed-african-american-and-hispanic-iv-drug-users-tested-in-2018-2019/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/raised-risk-of-of-blood-borne-virus-infection-and-other-drug-related-harms-among-people-who-inject-drugs-in-public-places/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/hcv-infection-risk-and-gender-vulnerability-of-women-who-inject-drugs/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/the-impact-of-opioid-agonist-treatment-on-mortality-among-people-who-inject-drugs-a-3-site-modelling-analysis/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/cost-effectiveness-of-hepatitis-c-virus-screening-and-treatment-with-direct-acting-antivirals-in-people-who-inject-drugs-in-nairobi-kenya/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/substance-use-mental-health-and-healthcare-costs-after-release-from-australian-prisons/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/barriers-to-hepatitis-c-diagnosis-and-treatment-in-the-daa-era-review-of-the-literature-and-results-of-a-community-based-survey-of-primary-care-practitioners/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/a-global-investment-case-for-hepatitis-c/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/upscaling-prevention-testing-and-treatment-to-control-hepatitis-c-as-a-public-health-threat-in-dar-es-salaam-tanzania/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/australia-will-need-to-increase-testing-to-achieve-hepatitis-c-elimination/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/set-up-to-fail-the-post-release-experience-of-prisoners-with-a-history-of-injection-drug-use/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/hepatitis-c-and-hiv-co-infection-among-people-who-use-drugs-and-other-key-populations-in-south-africa-findings-from-a-seven-city-cross-sectional-survey/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/a-standardization-model-for-estimating-populations-of-persons-who-inject-drugs-in-us-states-2017/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/when-treatment-access-does-not-equal-treatment-initiation-an-analysis-of-clients-who-do-not-initiate-direct-acting-antivirals/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/high-uptake-of-direct-acting-antiviral-therapy-for-hepatitis-c-virus-and-reduction-in-population-level-viremic-prevalence-progress-toward-achieving-hepatitis-c-elimination-among-people-who-inject-dru/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/assessment-of-hepatitis-c-screening-strategies-in-different-community-settings-in-a-canadian-metropolitan-area/ 2021-01-20T03:00:05+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-at-a-swedish-needle-exchange-program-a-successful-full-service-model-for-reaching-active-injectors/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/hepatitis-c-prevalence-and-risk-factors-among-people-who-engage-in-transactional-sex-work-philadelphia/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/health-care-access-among-drug-users-in-philadelphia/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/the-st-luc-cohort-a-longitudinal-study-serving-as-a-stepping-stone-to-hcv-treatment-initiation-among-people-who-inject-drugs/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/hepns-curbing-hepatitis-c-transmission-through-effective-linkage-of-people-who-inject-substances-to-treatment-in-nova-scotia-canada/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/pals-lending-a-hand-to-people-who-use-substances-transitioning-out-of-central-nova-scotia-canada-correctional-facility/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/linkage-to-care-added-value-of-c-buddies-in-the-treatment-of-hepatitis-c-in-persons-who-use-or-inject-drugs/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/implementing-best-practice-models-of-care-in-custodial-settings-in-australia-what-role-does-the-national-hepatitis-c-strategy-play/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/issues-of-adherence-to-the-opioid-substitution-therapy-in-the-north-of-morocco/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/reaching-out-to-the-undiagnosed-people-with-hepatitis-c-infection-in-belgium/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/treatment-of-hcv-hiv-co-infection-in-nhs-tayside-scotland-2001-2019/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/127-improved-linkage-to-hepatitis-c-assessment-and-treatment-within-community-drug-services-through-combined-hepatitis-c-and-opiate-substitution-treatment-prescription-appointments/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/community-based-approach-to-hepatitis-c-in-people-who-inject-drugs-in-pereira-colombia/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/a-cloud-based-approach-to-hepatitis-c-care-in-patients-with-substance-use/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/scaling-up-for-hepatitis-c-elimination-lessons-from-a-successful-partnership-between-an-hiv-and-homelessness-nursing-program-and-an-hiv-aids-service-organization-in-melbourne-australia/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/health-care-access-among-drug-users-in-philadelphia/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/hepatitis-c-prevalence-and-risk-factors-among-people-who-engage-in-transactional-sex-work-philadelphia/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-at-a-swedish-needle-exchange-program-a-successful-full-service-model-for-reaching-active-injectors/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/the-st-luc-cohort-a-longitudinal-study-serving-as-a-stepping-stone-to-hcv-treatment-initiation-among-people-who-inject-drugs/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/implementation-of-a-model-of-care-for-the-screening-and-treatment-of-hepatitis-c-in-the-obedjiwan-indigenous-community-with-the-goal-of-elimination/ 2021-01-20T03:00:13+00:00 https://www.inhsu.org/resource/a-peer-based-support-model-for-hcv-treatment-for-pwid-integrated-into-a-public-healthcare-facility-in-hanoi-vietnam/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/128-ask-a-friendidentifying-the-hidden-population-former-intravenous-drug-users-who-are-no-longer-in-contact-with-services-a-respondent-driven-sampling-protocol/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/a-nurse-led-community-based-model-of-hepatitis-c-care-in-melbourne-australia-2017-2018/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/a-model-of-care-for-people-attending-drug-treatment-centers-aiming-at-hepatitis-c-elimination-by-2022-a-part-of-the-c-free-south-strategy/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/can-patient-groups-lead-diagnosis-and-treatment-in-prisons-of-resource-limited-settings-we-are-doing-it/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/community-centric-hcv-testing-and-treatment-for-pwid-in-manipur-india-the-head-start-project/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/engaging-mother-infant-dyads-in-hepatitis-c-care-through-perinatal-pediatric-infectious-diseases-consultation/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/an-initiative-aimed-at-building-capacity-in-healthcare-organizations-to-provide-stigma-free-care-to-people-who-use-drugs/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/129-seamless-integration-of-hepatitis-c-treatment-within-an-intravenous-iv-hydromorphone-opioid-agonist-treatment-ioat-program/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/integrated-and-low-threshold-models-of-care-in-opioid-agonist-treatment-centers-are-we-there-yet-in-quebec/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/removing-health-insurance-barriers-and-incorporating-harm-reduction-with-a-physician-nurse-pharmacist-team-to-optimize-hepatitis-c-virus-hcv-treatment-in-a-u-s-co-located-hcv-methadone-mainten/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/accessing-the-inaccesible-an-innovative-approach-to-hepatitis-c-testing-and-treatment-in-the-community/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-in-hiv-patients-comparison-between-treatment-liver-specialty-vs-primary-care/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/approaches-to-providing-hepatitis-c-viremia-testing-to-people-who-inject-drugs-in-georgia-head-start-hepatitis-elimination-through-access-to-diagnostics-georgia/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/hepatitis-c-treatment-integration-with-harm-reduction-services-in-georgia-preliminary-findings/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/the-role-of-a-hepatitis-c-care-coordinator-in-providing-comprehensive-care-to-facilitate-hepatitis-c-treatment-among-people-who-inject-drugs/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/police-are-responsive-to-hepatitis-c-prevention-police-sensitization-with-a-hepatitis-c-entry-have-proven-to-be-more-effective-in-nairobi-kenya/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/efficacy-of-hcv-infection-treatment-using-a-go-to-the-patient-action-among-patients-not-attending-standard-medical-care-centres-with-active-substitued-drug-alcohol-addiction-and-or/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/a-community-based-approach-to-viral-hepatitis-in-central-appalachia/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/linkage-to-hcv-care-and-treatment-among-people-who-use-or-inject-drug/ 2021-01-20T03:00:21+00:00 https://www.inhsu.org/resource/good-practices-in-health-response-to-hcv-in-a-harm-reduction-program/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/a-proximity-harm-reduction-approach-to-improve-hcv-treatment-adherence/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/addressing-insufficient-hcv-knowledge-and-service-capacity-through-community-led-trainings-on-hcv-and-marginalized-populations-needs/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/the-optimal-strategy-of-hepatitis-c-therapy-in-genotype-1b-treatment-naive-patients-who-inject-drugs-in-china-a-decision-and-cost-effectiveness-analysis/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/partnering-with-consumers-the-development-of-a-primary-health-care-hepatitis-c-treatment-model-within-a-peer-based-needle-and-syringe-program/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/five-steps-into-the-trieste-integrate-model-for-treatment-of-hepatitis-c-in-people-who-inject-drugs/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/treating-people-where-they-are-nurse-led-hepatitis-c-hcv-micro-elimination-project-for-networks-of-people-with-recent-injecting-drug-use-in-victoria-canada/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/130-rural-us-drug-user-health-through-syringe-access-programming/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/increasing-access-to-addiction-services-for-indigenous-communities-in-quebec-an-integrated-model-of-care-between-onentokon-healing-lodge-indigenous-services-canada-and-the-centre-hospital/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/using-the-project-echo-model-of-care-to-increase-access-to-addiction-medicine-services-for-first-nations-and-inuit-communities-in-the-province-of-quebec/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/hiv-and-hcv-screenings-in-harm-reduction-settings-a-pilot-project-based-on-a-proximity-strategy/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/the-hepatitis-c-cascade-of-care-and-treatment-outcomes-among-people-who-inject-drugs-in-a-norwegian-low-threshold-setting-a-real-life-experience/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/model-of-care-peer-led-approach-on-treatment-of-hepatitis-c/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/successful-treatment-of-hepatitis-c-among-people-who-inject-drugs-in-nairobi-kenya/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/the-hepcare-model-of-integrated-care-improves-clinic-attendance-in-hard-to-reach-hepatitis-c-positive-patients/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/the-kombi-clinic-its-the-end-of-the-road-for-hepatitis-c/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/applying-behavioural-interventions-to-increase-hcv-screening-rates-in-community-drug-treatment-settings/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/get-tested-leeds-re-diagnosing-and-re-engaging-pwid-with-blood-borne-viruses-bbv-in-an-urban-emergency-department/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/supporting-primary-care-clinics-to-prioritise-hepatitis-c-testing-and-treatment-through-the-provision-of-a-tailored-package-of-interventions-the-ec-nurse-led-model/ 2021-01-20T03:00:29+00:00 https://www.inhsu.org/resource/project-ittreat-integrated-community-based-test-stage-treat-hcv-service-for-people-who-inject-drugs-clinical-patient-reported-and-health-economic-outcomes/ 2021-01-20T03:00:35+00:00 https://www.inhsu.org/resource/low-threshold-services-for-pwud-integrating-buprenorphine-into-a-comprehensive-hiv-hcv-and-sexual-health-care-and-treatment-program-in-new-york-city/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/micro-elimination-of-hepatitis-c-among-incarcerated-population/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/methadone-maintenance-treatment-program-mmtp-in-nepal-role-of-user-led-organizations-in-engaging-and-empowering-mmtp-patients/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/community-based-organization-spearheads-efforts-to-translate-hcv-interventions-to-prison-settings-in-jakarta/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/achieving-hepatitis-c-elimination-a-change-in-a-care-pathway-within-a-prison-increases-access-to-hepatitis-c-treatment/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/accessing-hidden-populations-an-extended-outreach-service-of-the-kirketon-road-centre/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/132-improving-svr12-follow-up-in-primary-care-with-a-structured-hepatitis-c-assessment-tool/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/micro-elimination-of-hepatitis-c-among-people-who-use-drugs-in-an-indigenous-community-in-saskatchewan-canada/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/viral-hepatitis-testing-and-linkage-to-care-for-individuals-enrolled-in-opioid-treatment-programs-in-denver-colorado/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/evaluation-of-the-xpert-hcv-viral-load-fingerstick-assay-in-the-harm-reduction-setting-in-catalonia-spain/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/viral-hepatitis-c-prevalence-incidence-injecting-practices-and-linkage-to-care-among-people-who-inject-drugs-participating-in-a-methadone-maintenance-therapy-pilot-project-in-cape-town-south-africa/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/a-cost-benefit-analysis-of-primary-versus-hospital-based-specialist-care-for-direct-acting-antiviral-hepatitis-c-treatment/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/naltrexone-xr-xr-ntx-can-be-used-to-support-hepatitis-c-virus-hcv-treatment-in-young-medically-withdrawn-persons-who-inject-drugs-pwids-a-preliminary-report/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/image-and-performance-enhancing-drugs-a-risk-for-hcv-or-fatty-liver-disease/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/national-prisons-hepatitis-network-facilitating-enhanced-infrastructure-and-scale-up-of-hcv-treatment-in-australian-prisons-towards-national-elimination/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/establishing-an-integrated-care-clinic-for-hcv-infected-people-who-actively-inject-drugs-pwid-at-a-harm-reduction-center-in-washington-dc-anchor-model/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/onsite-case-management-bridging-the-divide-between-hcv-diagnosis-and-treatment-for-people-who-inject-drugs/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/131-collaborative-working-with-community-pharmacies-increases-testing-and-enhances-access-to-direct-acting-antiviral-daa-therapy-for-hepatitis-c-hcv/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/effective-daa-hcv-treatment-and-care-model-among-people-who-inject-drugs-in-most-hard-to-reach-conflict-areas-in-northern-myanmar/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/a-perfect-storm-and-a-perfect-opportunity-the-story-of-an-innovative-hcv-screening-and-ltc-program-for-substance-users-in-georgia/ 2021-01-20T03:00:39+00:00 https://www.inhsu.org/resource/impacts-of-hepatitis-c-virus-infection-treatment-for-patients-in-treatment-for-opioid-use-disorder/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/overcoming-institutional-barriers-to-integrated-care-linkage-to-hepatitis-c-treatment-in-the-opioid-agonist-treatment-setting/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/a-two-eyed-seeing-approach-to-wholistic-healing-and-wellness-for-people-with-drug-use-experience/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/112-beyond-clinical-outcomes-impact-and-wider-social-and-healthcare-system-implications-of-hepatitis-c-virus-hcv-treatment-and-cure/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/113-hepatitis-c-treatment-peer-insights-to-understanding-enablers-and-impediments-to-daa-uptake-among-people-who-inject-drugs/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/peers4wellness-indigenous-model-for-supportive-hcv-and-hiv-care/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/perceived-barriers-to-and-facilitators-of-hcv-treatment-uptake-in-jail-and-linkage-to-hcv-care-after-incarceration-a-qualitative-study/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/the-ace-team-an-inner-city-outreach-team-for-high-barrier-hiv-and-hepatitis-c-individuals/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/pharmacist-led-hcv-screening-diagnosis-and-treatment-in-an-opioid-substitution-therapy-outpatient-pharmacy/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/an-on-site-nurse-led-protocol-driven-model-of-care-improves-access-to-hcv-treatment-for-transiently-incarcerated-persons-in-a-provincial-correctional-facility-in-saskatchewan-canada/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/mapping-hepatitis-c-services-to-remove-barriers-to-treatment-for-people-who-inject-drugs/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/www-working-within-walsall-to-eliminate-hepatitis-c-from-test-to-cure/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/the-impact-of-psychosocial-factors-on-the-care-cascade-for-hepatitis-c-treatment-at-a-harm-reduction-program/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/changes-in-housing-stability-and-treatment-for-opioid-use-disorder-during-hepatitis-c-treatment-at-a-harm-reduction-program/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/education-to-reduce-hiv-hbv-hcv-transmission-in-incarcerated-populations/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/integrating-hepatitis-c-care-with-mental-health-and-alcohol-and-other-drug-services/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/first-french-speaking-echo-hepatitis-c-telementoring-program-evaluation-at-year-two/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/addressing-the-hcv-cascade-of-care-in-vulnerable-populations-with-poor-access-to-healthcare-in-madrid-through-of-a-point-of-care-in-a-one-step/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/engaging-drug-using-communities-to-scale-up-diagnosis-and-inform-national-hiv-hcv-elimination-efforts/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/changes-in-attitudes-knowledge-and-everyday-life-throughout-direct-acting-antiviral-treatment-for-hepatitis-c-a-longitudinal-qualitative-study/ 2021-01-20T03:00:46+00:00 https://www.inhsu.org/resource/injecting-culture-following-prison-wide-hepatitis-c-treatment-scale-up-negotiating-risk-after-cur/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/factors-that-influence-people-who-use-drugs-experiences-with-direct-acting-antiviral-treatment-for-hepatitis-c-a-qualitative-study-in-vancouver-canada/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/117-factors-associated-with-low-rates-of-engagement-in-opioid-substitution-treatment-among-people-who-use-drugs-in-athens/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/116-hcv-crisis-among-russian-speaking-injecting-drug-users-in-france-the-urgent-need-to-improve-access-to-care-and-social-integration/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/120-the-implementation-of-harm-reduction-and-hepatitis-c-services-for-people-who-inject-drugs-in-europe-results-from-the-2018-hep-core-survey/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/using-a-systems-thinking-approach-to-elucidate-programme-theory-underpinning-the-effectiveness-of-superdot-c-a-pharmacy-led-test-and-treat-pathway-for-pwids-with-hepatitis-c-infection-prescribed-opio/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/promise-and-pharmaceuticalisation-in-the-era-of-direct-acting-antivirals/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/how-the-elimination-of-a-virus-came-to-be-modelling-and-the-life-of-targets/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/if-we-build-it-will-they-come-high-interest-in-sif-among-pwid-with-hcv-in-washington-dc/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/121-cost-of-hepatitis-c-care-facilitation-for-hiv-hepatitis-c-co-infected-people-who-use-substances/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/stamsh-slhanay-llhwat-warrior-women-healing/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/116-hcv-crisis-among-russian-speaking-injecting-drug-users-in-france-the-urgent-need-to-improve-access-to-care-and-social-integration/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/117-factors-associated-with-low-rates-of-engagement-in-opioid-substitution-treatment-among-people-who-use-drugs-in-athens/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/factors-that-influence-people-who-use-drugs-experiences-with-direct-acting-antiviral-treatment-for-hepatitis-c-a-qualitative-study-in-vancouver-canada/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/injecting-culture-following-prison-wide-hepatitis-c-treatment-scale-up-negotiating-risk-after-cur/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/life-and-loss-in-the-race-to-elimination-what-does-viral-elimination-potentiate-and-what-does-it-leave-behind/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/growing-old-with-drugs-preliminary-results-from-a-qualitative-study-on-the-aging-process-of-drug-users-in-opioid-substitution-treatment/ 2021-01-20T03:00:55+00:00 https://www.inhsu.org/resource/access-to-hepatitis-c-care-for-underserved-pwid-provision-rapid-testing-and-fibrosis-assessment-in-drug-consumption-rooms/ 2021-01-20T03:35:20+00:00 https://www.inhsu.org/resource/high-rate-of-hcv-reinfection-among-recently-injecting-drug-users-results-from-the-trap-hep-c-program-in-iceland-a-prospective-nationwide-population-based-study/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/deliver-care-bringing-mobile-hcv-services-to-the-san-francisco-community/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/fentanyl-concentration-in-drug-checking-samples-and-risk-of-drug-related-mortality-during-an-illicit-drug-toxicity-crisis-in-vancouver-canada-a-time-series-analysis/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/declining-prevalence-of-current-hcv-infection-associated-with-increased-treatment-uptake-among-people-who-inject-drugs-the-ethos-engage-study/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/interventions-to-enhance-testing-and-treatment-uptake-for-hepatitis-c-infection-a-systematic-review-and-meta-analysis/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/use-of-primary-care-based-medication-for-opioid-use-disorder-facilitates-broader-health-service-utilisation-following-release-from-prison/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/comparison-of-outcomes-of-partially-decentralised-hcv-care-in-primary-healthcare-sites-for-pwid-and-non-pwid-populations-in-malaysia-the-head-start-project/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/exploring-perspectives-of-people-who-use-drugs-on-hospital-based-interventions-for-hepatitis-c-treatment-using-an-access-to-care-integrated-framework-a-qualitative-analysis/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/injecting-as-a-social-practice-illuminating-the-party-and-play-practice-bundle-among-gay-and-bisexual-men-in-australia/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/a-peer-led-mobile-hcv-clinic-for-people-who-inject-drugs-outside-the-urban-centers/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/point-of-care-hcv-rna-testing-linkage-to-nursing-care-and-peer-supported-engagement-and-delivery-to-enhance-hcv-treatment-among-people-with-recent-injecting-drug-use-at-a-community-led-needle-and-sy/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/reducing-stigma-towards-groups-affected-by-blood-borne-viruses-an-online-intervention-study/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/fear-of-inpatient-opiate-withdrawal-a-modifiable-barrier-to-health-care-access-for-people-who-use-illicit-opiates/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/correctional-officers-and-health-staff-perspectives-of-hepatitis-c-treatment-as-prevention-scale-up-within-the-prison-setting/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/early-phase-implementation-of-routine-opt-out-hepatitis-c-testing-in-the-philadelphia-jail-system/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/high-uptake-of-treatment-and-cure-rates-in-a-decentralized-community-based-general-practitioner-led-hepatitis-c-model-of-care-for-people-who-inject-drugs-and-people-affected-by-liver-disease-in-yangon/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/comparison-of-fully-decentralized-and-partially-decentralized-models-of-hcv-testing-and-treatment-for-pwid-in-manipur-india-the-head-start-project/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/rapid-point-of-care-hcv-testing-allows-high-throughout-hcv-screening-and-rapid-treatment-uptake-among-pwid-attending-a-medically-supervised-injecting-room/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/hepatitis-c-test-and-treat-roadshow-reaching-homeless-communities/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/integration-of-hepatitis-c-treatment-with-harm-reduction-services-for-people-who-inject-drugs-pwids-in-kenya-experience-form-test-and-link-to-care-tlc-study/ 2022-04-07T05:14:55+00:00 https://www.inhsu.org/resource/hepatitis-c-virus-reinfection-following-direct-acting-antiviral-treatment-in-the-prison-setting-the-stop-c-study/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/trends-in-chronic-hepatitis-c-infection-among-people-who-inject-drugs-in-england-real-world-data-2011-2018/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/stigma-is-where-the-harm-comes-from-exploring-expectations-and-lived-experiences-of-hepatitis-c-virus-post-treatment-trajectories-among-people-who-inject-drugs/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/the-c-link-trial-a-prospective-randomised-controlled-trial-showing-than-care-navigation-post-release-from-prisons-increases-linkage-to-hepatitis-c-care/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/switching-from-a-criminalisation-to-a-public-health-approach-to-injecting-drug-use-in-eastern-europe-and-central-asia-a-modelling-analysis-of-the-costs-and-impact-on-hiv-transmission/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/three-armed-cluster-intervention-study-of-hepatitis-c-viremia-testing-for-people-who-inject-drugs-in-georgia/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/a-novel-hepatitis-c-intervention-in-denmark-to-test-and-treat-people-who-inject-drugs/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/treating-people-in-covid-19-sheltering-sites-nurse-led-hepatitis-c-hcv-micro-elimination-project-during-dual-public-health-emergencies-for-people-who-inject-drugs-pwid-in-victoria-canada/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/hep-c-u-later-a-national-health-service-nhs-addiction-misuse-providers-alliance-nhsapa-system-wide-partnership-approach-to-eliminating-hepatitis-c-hcv/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/no-going-back-to-normal-in-hepatitis-c-hcv-care-post-covid-19/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/the-power-of-peers-increasing-the-uptake-of-hcv-testing-and-treatment-amongst-people-who-inject-drugs/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/addition-of-patient-navigator-and-social-worker-to-interdisciplinary-hepatitis-c-team-increases-treatment-uptake-results-of-the-prospective-randomized-controlled-care-c-trial/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/same-day-delivery-hcv-point-of-care-testing-in-southeast-queensland-marginalised-communities-simplifies-diagnosis-and-ensures-rapid-access-to-treatment/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/hcv-virtual-the-use-of-a-web-based-tool-to-assist-in-management-and-follow-up-of-patients-with-hcv/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/hepatitis-c-single-attendance-test-assess-and-treat-hep-stat-minimizes-care-cascade-attrition-and-achieves-high-rates-of-treatment-initiation-completion-and-cure-in-people-who-inj/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/enhancing-the-hepatitis-c-care-cascade-among-people-in-custody-in-iran/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/pharmacist-led-telephone-clinic-is-an-effective-strategy-for-treating-patients-with-hepatitis-c-and-removing-barriers-to-engagement/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/high-levels-of-uptake-and-use-of-naloxone-among-participants-in-a-take-home-naloxone-program-in-stockholm-sweden/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/determinants-of-long-term-retention-in-opioid-agonist-therapy-among-people-who-inject-drugs-in-montreal-canada/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/reduced-hepatitis-c-incidence-associated-with-rapid-treatment-scale-up-in-australian-prisons-treatment-as-prevention-in-the-stop-c-study/ 2022-04-07T05:15:54+00:00 https://www.inhsu.org/resource/vp112-working-to-eliminate-hepatitis-c-hcv-in-west-virginia-wv/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/vp140-cost-effectiveness-of-pharmacy-led-versus-conventionally-delivered-antiviral-treatment-for-hepatitis-c-in-patients-receiving-opioid-substitution-therapy-an-economic-evaluation-alongside-a-pra/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/developing-a-theory-informed-pathway-for-primary-care-initiated-hepatitis-c-virus-treatment-in-scotland/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/a-global-systematic-review-of-efforts-to-accelerate-the-elimination-of-hepatitis-c-through-micro-elimination-among-pwid-and-other-target-populations/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/diagnostic-accuracy-of-assays-using-finger-stick-capillary-and-dried-blood-spot-samples-for-determination-of-hepatitis-c-rna-detection-a-systematic-review-and-meta-analysis/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/weve-had-a-circuit-breaker-for-an-old-dogma-of-more-than-20-years-changes-to-opioid-agonist-treatment-services-during-covid-19-the-choice-study/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/impact-of-drug-consumption-rooms-on-non-fatal-overdoses-abscesses-and-emergency-room-visits-in-people-who-inject-drugs-in-france-results-from-the-cosinus-cohort/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/experiences-of-advanced-peer-support-workers-as-they-progress-from-peer-to-professional-a-qualitative-evaluation/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/trends-and-factors-associated-with-drug-use-in-south-africa-findings-from-multiple-national-population-based-household-surveys/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/peer-facilitated-telemedicine-hepatitis-c-treatment-for-rural-people-who-use-drugs-early-experience-from-a-randomized-trial/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/preferences-for-a-one-stop-shop-intervention-integrating-point-of-care-hcv-rna-testing-versus-standard-of-care-to-enhance-hepatitis-c-testing-and-treatment-among-new-receptions-to-pr/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/does-take-home-naloxone-program-participation-result-in-the-use-of-naloxone-at-witnessed-overdoses-findings-from-a-cohort-study-of-the-implementation-of-the-unodc-who-stop-overdose-safely-initiative/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/impact-of-covid-19-restrictions-on-hepatitis-c-testing-at-primary-care-and-community-health-services-in-victoria-australia/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/preferences-for-opioid-agonist-treatment-among-people-who-regularly-use-opioids-in-australia-the-prefer-study/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/violence-and-hepatitis-c-transmission-in-prison-a-modified-social-ecological-model/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/rapid-hep-c-point-of-care-rna-testing-and-treatment-at-an-integrated-supervised-consumption-service-in-toronto-canada/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/vp20-complete-harm-reduction-package-for-people-who-use-drugs-pilot-project-in-maputo-mozambique/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/vp114-dorset-pop-up-hepatitis-c-hcv-clinics-reaching-the-unreachable-engaging-the-disengaged/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/vp104-hcv-testing-and-treatment-at-syringe-exchange-program-in-new-york-city-during-covid-19/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/vp111-hepatitis-c-elimination-during-a-global-pandemic-resilience-in-action/ 2022-04-07T05:16:57+00:00 https://www.inhsu.org/resource/vp79-hcv-reinfection-is-common-in-people-entering-prisons-in-catalonia-spain-re-hcv-study/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp08-not-all-decriminalisation-is-created-equal-mapping-non-criminal-responses-to-drug-use-and-related-activities-globally/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp70-homelessness-unstable-housing-and-risk-of-hiv-and-hepatitis-c-virus-acquisition-among-people-who-inject-drugs-a-systematic-review-and-meta-analysis/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp52-interventions-to-increase-linkage-to-care-and-adherence-to-treatment-for-hepatitis-c-among-people-who-inject-drugs-a-systematic-review/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp37-conceptualising-hepatitis-c-stigma-a-thematic-synthesis-of-qualitative-research/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp102-assessing-the-impact-of-covid-19-and-associated-control-measures-on-interventions-to-prevent-blood-borne-viruses-among-people-who-inject-drugs-in-scotland/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp82-hcv-diversity-and-treatment-outcomes-following-direct-acting-antiviral-daa-therapy-in-benin/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp18-protective-associations-between-opioid-agonist-treatment-and-fatal-opioid-overdose-vary-with-time-and-age-findings-from-the-opioid-agonist-treatment-and-safety-oats-study-new-south-wales-a/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp120-insights-into-the-drivers-of-variations-in-hiv-epidemic-patterns-among-people-who-inject-drugs-in-pakistan/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp01-modelling-the-impact-of-unsupervised-injectable-opioid-agonist-therapy-with-other-opioid-therapy/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp80-reinfection-following-successful-direct-acting-antiviral-therapy-for-hcv-infection-among-people-attending-an-inner-city-community-health-centre-in-victoria-canada/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp110-blood-borne-virus-bbv-testing-in-prisons-best-practice-toolkit-for-reception-based-pathways/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp84-impact-of-direct-acting-antiviral-treatment-on-mortality-related-to-extrahepatic-manifestations-findings-from-a-large-population-based-cohort-in-british-columbia-canada/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp68-the-civil-society-monitoring-of-progress-in-hepatitis-c-response-for-people-who-inject-drugs-related-to-the-who-2030-elimination-goals-in-35-european-countries/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp30-retrospective-review-of-the-truenorth-medical-centres-database-in-canada-assessment-of-the-impact-of-simplified-care-on-direct-acting-antivirals-treatment-for-hepatitis-c-virus-patients-in-add/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp138-lessons-learned-in-alabamas-hcv-work-with-the-pwid-population/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp33-achieving-hepatitis-c-virus-hcv-elimination-in-prisons-through-hcv-intensive-test-and-treat-hitt-interventions/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp16-enhancing-health-care-for-pwuds-through-advocacy-for-universal-health-coverage-uhc-for-hcv-harm-reduction/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp29-a-guide-to-scale-up-of-testing-and-treatment-for-hepatitis-c-in-the-prison-setting-the-stop-c-implementation-toolkit/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp11-trends-in-amphetamine-injection-and-predictors-of-initiation-among-people-who-inject-drugs-in-montreal-canada-2011-2019/ 2022-04-07T05:18:03+00:00 https://www.inhsu.org/resource/vp71-trends-in-time-to-treatment-initiation-among-people-diagnosed-with-hepatitis-c-in-a-network-of-australian-clinical-services-between-2015-2019/ 2022-04-07T05:19:03+00:00 https://www.inhsu.org/resource/vp61-hcv-treatment-uptake-among-marginalized-people-who-inject-drugs-in-norway-a-registry-based-study/ 2022-04-07T05:19:03+00:00 https://www.inhsu.org/resource/vp97-determinants-of-psychological-distress-during-the-covid-19-pandemic-among-people-who-use-drugs-in-montreal-canada/ 2022-04-07T05:19:03+00:00 https://www.inhsu.org/resource/vp60-methods-and-indicators-to-validate-country-responses-for-decreasing-incidence-of-hepatitis-c-virus-infection-to-elimination-levels-set-by-the-world-health-organization/ 2022-04-07T05:19:03+00:00 https://www.inhsu.org/resource/vp56-opportunity-for-targeted-hepatitis-c-health-messaging-for-sub-populations-of-people-who-inject-drugs-in-melbourne-a-latent-class-analysis/ 2022-04-07T05:19:03+00:00 https://www.inhsu.org/resource/vp105-increased-hepatitis-c-screening-and-diagnosis-after-transfer-of-health-care-responsibility-to-public-health-system-in-british-columbia-correctional-centres/ 2022-04-07T05:19:03+00:00